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ABSTRACT

The sodium-hydrogen exchanger isoform 3 (NHE3, SLC9A3) mediates most
Na+/H+ exchange in the gastrointestinal tract and the kidney, where it plays crucial roles
in Na+ and fluid absorption as well as acid-base homeostasis. Whole body NHE3
knockout (NHE3-/-) mice show overt absorptive defects in both the intestine and kidneys.
Genetic mutations of NHE3 gene in humans are associated with congenital sodium
diarrhea (CSD). In the kidneys, NHE3 is expressed in the proximal tubule (PT) and the
thick ascending limb (TAL). Whole kidney-specific (PT and TAL) NHE3 knockout
(NHE3Pax8cre) mice and PT-specific NHE3 knockout (PT-NHE3-/-) mice have shown the
importance of renal NHE3 in Na+ homeostasis and blood pressure regulation. To date,
the relative contribution of NHE3 in the intestine versus the kidneys and the role of
NHE3 in the TAL for Na+, fluid and acid-base homeostasis not been selectively
investigated due to a lack of suitable animal models. To fill these two knowledge gaps,
two series of experiment were conducted by using novel tamoxifen inducible intestinal
epithelial cell specific (NHE3IEC-KO) and TAL-specific NHE3 knockout (NHE3TAL-KO)
mouse models. 1) No difference was found in blood parameters or other phenotypes
between NHE3IEC-KO and control (NHE3loxlox) mice before tamoxifen administration. After
tamoxifen administration, NHE3 was completely deleted in the intestine of NHE3IEC-KO
mice. Loss of NHE3 causes defective intestinal absorption, indicated by watery, alkaline
diarrhea and dilated intestine associated with a compensatory higher fluid intake in
iv

NHE3IEC-KO mice. Three weeks after tamoxifen, ~25% mortality rate is found in NHE3IECKO

mice. NHE3IEC-KO mice also show metabolic acidosis, lower blood bicarbonate levels,

hyponatremia and hyperkalemia in combination with drastically elevated plasma
aldosterone levels. These results indicate that intestinal NHE3 plays a significant role in
acid-base, Na+ and volume homeostasis. This NHE3IEC-KO mouse model provides a
suitable tool for studying the role of intestinal NHE3 and explains the phenotype of
individuals with CSD carrying SLC9A3 mutations. 2) After tamoxifen administration,
deletion of NHE3 in the TAL was confirmed by mRNA expression and
immunofluorescent staining. Two weeks after tamoxifen administration, NHE3TAL-KO
mice showed a ~25% lower urine osmolality associated with ~20% higher water intake
compared to Con mice. No differences were found in blood pH, urinary pH, urinary Na+
or Cl-/creatinine ratios or glomerular filtration rate. Of note, NHE3TAL-KO mice have a
higher K+/creatinine ratio compared to control mice. To test for a role of the TAL in
urinary acidification we used furosemide which stimulates urinary acidification. In
response to furosemide no dose-dependent differences were observed in Cl- excretion
or urinary flow rate. Of note, NHE3TAL-KO mice showed an acute decrease in urinary pH
similar to control mice followed by an immediate recovery of urinary pH, the latter
completely absent in control mice. Taken together, the results indicate that NHE3 in the
TAL contributes to urinary concentrating ability and the sustained response of the TAL
to furosemide-induced urinary acidification. The new NHE3TAL-KO mouse model provides
a useful tool to delineate the specific role of NHE3 in the TAL for renal functions. This
thesis provides unprecedent insights into the functions of NHE3 in the intestine and TAL
of the kidneys.
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CHAPTER ONE:
INTRODUCTION AND BACKGROUND

Sodium Homeostasis
As one of the most important electrolytes in the human body, sodium (Na+), is
extensively involved in basic life functioning, including neuron and muscle excitability,
maintenance of extracellular volume, fluid balance, etc. (Daniels and Fluharty 2004,
Pohl, Wheeler et al. 2013). Na+ is the principal osmotically active cation in the
extracellular fluid. Na+ and associated anions (chloride and bicarbonate) are responsible
for up to 88% of plasma osmolality (Damkjaer, Isaksson et al. 2013). Based on the
critical roles in the human physiology, plasma Na+ concentration is required to be
maintained within a narrow range (140 ± 5 mmol/L). Disturbances in plasma Na+
concentration can cause either hypernatremia (plasma Na+ > 145 mmol/L) or
hyponatremia (plasma Na+ < 136 mmol/L) which both can result in lethal consequences
(Seay, Lehrich et al. 2020). Hypernatremia represents deficient water in relation to
existing Na+ in the extracellular fluid, which can be caused by excessive salt gain or a
net water loss (Adrogue and Madias 2000, Lindner and Funk 2013). Water loss can
occur, e.g., by sweating during prolonged physical activity in high environmental
temperatures (Popkin, D'Anci et al. 2010). Rare causes for water loss are due to a
defect in urinary concentrating ability, which is a consequence of either decreased
arginine-vasopressin (AVP) secretion from the posterior pituitary (central diabetes
1

insipidus) or an impaired response of the kidneys to antidiuretic hormone (nephrogenic
diabetes insipidus) (Laczi 2002, Dabrowski, Kadakia et al. 2016). Additionally,
hypernatremia can also result from increased Na+-concentrated food intake (Seay,
Lehrich et al. 2020). In contrast, hyponatremia is caused by excess water gain or loss of
Na+ (Adrogue and Madias 2000, Schrier, Sharma et al. 2013). Loss of Na+ can occur in
a variety of conditions, including diarrhea and vomiting (Adrogue and Madias 2000),
overuse of diuretics or rare diseases like Addison’s disease (Vita, Silverberg et al.
1985), Bartter syndrome or Gitelman syndrome (Cunha and Heilberg 2018, Fulchiero
and Seo-Mayer 2019).

Figure 1. Maintenance of Na+ homeostasis in the body

As shown in Figure 1, maintenance of Na+ homeostasis in the body is
accomplished by the concerted responses of multiple organs, including gut, kidney, and
skin (Bie 2018). The precise regulation of Na+ intake and excretion also require
endocrine signaling pathways acting on various organs (Stanhewicz and Kenney 2015,
Sugar, Agocs et al. 2018). The gastrointestinal tract is responsible for Na+ uptake into
2

the body, whereas the output of Na+ is mediated by excretion in the urine and feces as
well as loss via sweat. Urine is the predominating route for Na+ excretion, accounting for
~90% of Na+ excretion (Armanini, Bordin et al. 2019). The Na+ loss by sweat and
excretion via the feces is responsible for the remaining 10%; however, the former can
be highly variable (Consolazio, Matoush et al. 1963).
The small intestine accounts for most of the nutrient and up to 90% water
absorption, with the remaining absorption occurring in the colon. Approximately 8-10 L
of fluid containing 18.4 g of Na+ is absorbed by the gastrointestinal tract every day
(Surawicz 2010, Kiela and Ghishan 2016). Inhibition of Na+ absorption by bacterial
infection and gastrointestinal illnesses (such as inflammatory bowel disease and irritable
bowel syndrome) can cause severe diarrhea, which could be life-threatening if not
corrected within a few days. Diarrhea is a major cause of morbidity and mortality for
children in the developing countries (Guerrant, Schorling et al. 1992, Bhutta, Bird et al.
2000, Getachew, Guadu et al. 2018).
In humans daily Na+ intake can be highly variable, ranging from ~23 mg/day
among the Yanomamo Indians (Oliver, Cohen et al. 1975, Mancilha-Carvalho, de
Oliveira et al. 1989) up to 10.5 g/day in north-east Japan (Dahl 2005). Therefore, this
huge variability of Na+ intake is a challenging task for the kidneys, which requires the
kidneys to adjust Na+ excretion to precisely match Na+ intake. For example, under some
extreme conditions of salt restriction (Nadal, Pedersen et al. 1941, Oliver, Cohen et al.
1975, Elijovich, Weinberger et al. 2016), the urinary Na+ excretion may drop virtually to
zero (below 0.5 mmol/L). This is accomplished by complex transport processes along
the nephron. The ultimate fine adjustment of Na+ excretion is accomplished in the
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aldosterone-sensitive distal nephron (parts of the late distal tubule, connecting tubule
and collecting duct).

Molecular Physiology for Sodium Transport
One of the major characteristics of intestinal and renal epithelial cells is apicalbasal polarity with asymmetric distributions of a variety of channels, transporters and
pumps. Na+ transport can be mediated by trans- and paracellular pathways, the former
is crucial and tightly regulated in both the intestine and the kidney. Transcellular Na+
transport is considered to be secondary active. The driving force for apical Na+ uptake is
created by the basolateral Na+-K+-ATPase which consequently allows for transcellular
Na+ transport against its electrochemical gradient (Figure 2).

Figure 2. Transcellular transport of Na+ across epithelial cells (adapted from
molecular biology of the cell, 6th edition)

4

Intestinal Na+ absorption
At least, three known mechanisms contribute to active Na+ absorption in the
different segments of the intestine, including (a) nutrient-coupled Na+ absorption, (b)
electroneutral Na+ absorption and (c) electrogenic Na+ absorption. Nutrient-coupled Na+
absorption is mediated by several Na+-dependent symporters, including sodium-glucose
cotransporter 1 (SGLT1) (Gorboulev, Schurmann et al. 2012, Rieg and Vallon 2018),
type II Na+-dependent phosphate cotransporter 2b (Npt2b) (Sabbagh, O'Brien et al.
2009), Na+-dependent amino acid cotransporters (Broer 2014), and short chain fatty
acid coupled Na+ absorption (den Besten, van Eunen et al. 2013). In the small intestine
and proximal colon, electroneutral Na+ absorption is functionally coupled with Clabsorption, occurring via coordinated action of Na+/H+ exchanger (mainly by NHE3)
(Schultheis, Clarke et al. 1998) and Cl-/HCO3- exchangers (DRA, downregulated in
adenoma or PAT1, putative anion transporter-1) (Kato and Romero 2011). Electrogenic
Na+ absorption, predominating in the distal colon, is attributed to apical epithelial sodium
channel (ENaC).

Renal tubular Na+ reabsorption
In the kidney, the nephron is the smallest functional unit, composed of
glomerulus, tubule and duct. Na+ reabsorption occurs in almost every nephron segment,
with the exception of the thin descending limbs of the loop of Henle. However, the Na+
transport capacity varies highly between nephron segments, resulting from specialized
Na+ channels and transporters expressed in the apical and basolateral membrane of
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distinctive nephron segments. For an overview of the majority of apical Na+ transporting
proteins, see Figure 3.

Figure 3. Nephron structural anatomy and Na+ transporters and channels on
different segments

Proximal tubule (PT) has a high reabsorption capacity, accounting for 60%-70%
Na+ reabsorption (Palmer and Schnermann 2015). In the PT, Na+/H+ exchange,
mediated by apically localized NHE3, is responsible for the vast majority of Na+
reabsorption (Vallon, Schwark et al. 2000, Alexander, Dimke et al. 2013). Of note,
almost all of H+ secreted by NHE3 in the PT is used for HCO3- reabsorption by the
action of carbonic anhydrase (Rector, Carter et al. 1998).
The loop of Henle is structurally and functionally heterogenous, composed of the
thin descending limb, thin ascending limb, and thick ascending limb (TAL). The thin
descending limb has low permeabilities for Na+ and other electrolytes (Kokko 1970).
The thin ascending limb is impermeable to water but can absorb Na+, which is
presumably by passive paracellular pathway due to low Na+/K+-ATPase level. In
6

Contrast, a large amount, 25%-30%, of Na+ reabsorption occurs in the TAL (Mount
2014). The vast majority of Na+ reabsorption in the TAL is mediated by apical
transporters, Na+/K+/2Cl- cotransporter (NKCC2) and NHE3 (Mount 2014, GonzalezVicente, Saez et al. 2019). NKCC2 and NHE3 are functionally coupled to apical renal
outer medullar K+ channel (ROMK), basolateral Cl- channel (ClC-Kb) and Na+/HCO3cotransporter (NBCe1), as well as other cotransporters and exchangers (Greger 1985).
Of note, the TAL is nearly impermeable to water. Thus, the tubular fluid will get diluted
when it passes through the TAL, with reabsorption of electrolytes but not water, which
explains why the TAL is also referred to as the diluting segment (Mount 2014).
The distal convoluted tubule (DCT) is the initial nephron segment downstream of
the macula densa (Reilly and Ellison 2000). Approximately 5%-10% of filtered Na+ is
reabsorbed in the DCT (Hierholzer and Wiederholt 1976). In the DCT, the main apical
Na+ transport is mediated by Na+/Cl- cotransporter (NCC), which is the targeted of
thiazide diuretics (Velazquez, Ellison et al. 1987). Following the DCT are the connecting
duct (CNT) and collecting duct (CD), the latter can be further divided into cortical
collecting duct (CCD), outer medullary collecting duct (OMCD) and inner medullary
collecting duct (IMCD) (Kokko 1987). After passing the DCT, only a small amount of Na+
remained in the tubular fluid. Therefore, only a minor fraction of filtered Na+ is
reabsorbed in the CNT and CD. However, the amount can be highly variable to match
Na+ intake. The major apical Na+ entry in the CNT and CD is via ENaC located in
principal cells (Palmer and Frindt 1986, Pacha, Frindt et al. 1993, Frindt and Palmer
2004).
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Sodium Homeostasis and Blood Pressure
Hypertension is defined as systolic blood pressure ≥140 mmHg and/or diastolic
blood pressure ≥90 mmHg. Hypertension is a major risk factor of cardiovascular
diseases and stroke (Ettehad, Emdin et al. 2016, Feigin, Roth et al. 2016, Benjamin,
Virani et al. 2018). It was estimated that more than 30% of adults worldwide (1.39 billion
people) were diagnosed with hypertension in 2010 (Mills, Bundy et al. 2016). It has
been commonly accepted that excessive dietary salt intake is closely linked to the
development of hypertension, and restriction of dietary salt intake has been shown to
lower blood pressure (Sacks, Svetkey et al. 2001, Aburto, Ziolkovska et al. 2013,
Juraschek, Woodward et al. 2017). In the Prospective Urban Rural Epidemiology
(PURE) study of 102216 adults from 18 countries of 5 continents, it reported a positive
association between estimated 24-hour urinary Na+ excretion (as a surrogate for Na+
intake) and blood pressure (Mente, O'Donnell et al. 2014). After regression analysis, a
steep slope was found for this association, with each 1-g increment in estimated Na+
excretion for increments of ~2 mm Hg in systolic blood pressure and ~1 mm Hg in
diastolic blood pressure.
Although the close relationship between blood pressure and dietary Na+ intake
has been well established, there is a significant variability of the blood pressure
response to changes in salt loading at the population level. Humans and different
animal models can be either salt-resistant, with relatively constant blood pressure in
response to variations in salt intake, or salt-sensitive with changes in blood pressure
going in parallel to changes in the salt intake (Luft and Weinberger 1982, Weinberger,
Miller et al. 1986). The pathophysiological mechanisms for salt sensitive hypertension
8

have been extensively studied. The fundamental and conceptual framework is proposed
by Guyton and coworkers, stressing the key role of the kidneys in long-term blood
pressure regulation (Guyton, Coleman et al. 1972). The essential principle of this
framework is that the function of reno-cardiovascular system is required to adapt to
changes in the salt intake to maintain a normal Na+ balance via pressure natriuresis. As
an osmotically active cation, high Na+ intake results in water retention and an expansion
of extracellular fluid volume, thus increased cardiac output and elevated renal perfusion
pressure. In the salt-resistant subjects, this high renal perfusion pressure triggers a
sufficient natriuresis, causing a rise in renal Na+ excretion to return the normal Na+
balance and extracellular fluid volume (Guyton 1991). However, in the salt-sensitive
subjects, this pressure-natriuresis relationship is disturbed, and thus higher pressure is
required for natriuresis to balance the Na+ excretion with Na+ intake.

Sodium Hydrogen Exchanger Family
Na+/H+ exchangers (NHEs) are transmembrane proteins which are highly
evolutionarily conserved at the function and structure level from prokaryote to eukaryote
(Counillon and Pouyssegur 1993, Pedersen and Counillon 2019). Mammalian NHEs
mediate electroneutral exchange of cytosolic H+ with extracellular/organellar Na+ with a
stoichiometry of 1:1 (Grinstein, Cohen et al. 1984, Grinstein, Goetz et al. 1984, Jean,
Frelin et al. 1985). This Na+/H+ exchange process and its full physiological significance
have been extensively investigated. NHEs are involved in numerous physiological
processes (Orlowski and Grinstein 2011, Pedersen and Counillon 2019), including but
not limited to cytosolic and organellar pH regulation, transepithelial transport, systemic
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and cellular volume regulation, scaffolding and signaling functions, cell proliferation and
apoptosis, as well as cell adhesion and motility.
Considerable diversity exists in the NHE gene family. To date, at least 11 NHE
isoforms have been identified in humans and other mammals. These NHE isoforms are
expressed in different tissue and cellular localization. They can be further
phylogenetically divided into three main clusters (Orlowski and Grinstein 2011). The first
cluster is the plasma membrane-type NHEs, including NHE1-5. The second cluster is
the organellar-type NHEs, including NHE6-9 (of note, NHE8 is also expressed in the
apical plasma membrane). The third cluster consist of NHA1 and NHA2, which are
evolutionarily distant from NHE1-9, but close to prokaryotic Na+/H+ antiporters (Brett,
Donowitz et al. 2005). This thesis focuses on NHE isoform 3 and therefore other NHEs
are not discussed here. The interested reader is referred to several excellent reviews
(Yun, Tse et al. 1995, Orlowski and Grinstein 2011, Donowitz, Ming Tse et al. 2013, Xu,
Ghishan et al. 2018, Pedersen and Counillon 2019).

NHE3
NHE3 is one of the most extensively studied Na+/H+ exchangers and has a broad
expression pattern with its main presence in the apical membrane of epithelial cells of
the intestine, kidney, and gall bladder (Orlowski, Kandasamy et al. 1992, Hoogerwerf,
Tsao et al. 1996, Schultheis, Clarke et al. 1998, Chen, Kong et al. 2014). NHE3 is also
expressed at a low level in different cells of other tissues and organs, including
stomach, epididymis, ovary, thymus, prostate, and brain (Brant, Yun et al. 1995).
Physiologically, the majority of Na+ (re)absorption in both the intestine and the PT of
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kidneys is mediated by NHE3. NHE regulatory factors (NHERFs) serve as a scaffold
protein allowing NHE3 to form multiprotein complexes with other transporters and
regulatory factors (Donowitz, Cha et al. 2005, Cha and Donowitz 2008). Studies in
genetically modified mice showed that whole body knockout of NHE3 causes diarrhea,
metabolic acidosis, dilated intestines with increased intestinal content, and high
mortality (Schultheis, Clarke et al. 1998, Bradford, Sartor et al. 2009). Clinically,
mutations in NHE3 are associated with CSD resulting from the defective Na+ and fluid
absorption (Janecke, Heinz-Erian et al. 2015).
The regulation of NHE3 occurs at multiple levels, including transcription (Baum,
Amemiya et al. 1996, Kandasamy and Orlowski 1996, Klisic, Zhang et al. 2003), protein
abundance, trafficking (Yang, Zhong et al. 2003, Leong, Yang et al. 2004, Yang,
Maunsbach et al. 2004, Bobulescu, Dwarakanath et al. 2005), phosphorylation (Peng,
Moe et al. 1999, Zhao, Wiederkehr et al. 1999, Hu, Fan et al. 2001, Sarker, Gronborg et
al. 2008) and protein-protein interactions (Donowitz and Li 2007).
NHE3 can recycle between apical membrane and intracellular endosomes
(Chow, Khurana et al. 1999, Alexander, Furuya et al. 2005). The trafficking of NHE3
between compartments acts as a mean to regulate apical NHE3 activity and
abundance. For example, dopamine reduces NHE3 exocytosis via the protein kinase A
(PKA) signaling pathway, resulting in decreased cell surface NHE3 abundance (Hu,
Bobulescu et al. 2017), which is consistent with the effect of parathyroid hormone (PTH)
on NHE3 trafficking (Bezerra, Girardi et al. 2008). In addition to recycling between
plasma membrane and intracellular endosomes, NHE3 is also able to redistribute from
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the body of microvilli to intermicrovillar clefts in the renal proximal tubule, which is
involved in pressure natriuresis (Yip, Tse et al. 1998).
NHE3 has a short N-terminus, 12 transmembrane domains followed by a long Cterminal domain (Figure 4) (Alexander and Grinstein 2009, Donowitz, Mohan et al.
2009). The latter domain is where multiple protein binding sites exist, such as ezrin
(Cha, Tse et al. 2006, Cha and Donowitz 2008), NHERFs (Donowitz, Cha et al. 2005) or
calcineurin homologous protein (CHP) (Pang, Su et al. 2001, Di Sole, Cerull et al.
2004). The protein-protein interaction of NHE3 with regulatory binding partners and
complexes is covered in detail in the following review (Donowitz and Li 2007).

Figure 4. The structure of NHE3. (adapted from R. Todd Alexander and Sergio
Grinstein, 2009, (Alexander and Grinstein 2009))
NHE3 structure is bipartite, a short N-terminus with 12 pass transmembrane
domains followed by a long C-terminal domain, where multiple protein binding
sites exist, including ezrin, DPP-IV (dipeptidyl peptidase IV), CHP (calcineurin
homologous protein), PKA (protein kinase A), SGK (serum and glucocorticoid
kinase), NHERFs (sodium hydrogen exchanger regulatory family), etc..
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Hypothesis
NHE3 is of major importance for Na+ (re)absorption in both the intestine and the
kidneys. To date, several transgenic mouse models have been developed to investigate
the role of NHE3, including NHE3 global knockout mice, global knockout with transgenic
rescue of the intestine, PT-specific knockout mice, and kidney-specific knockout mice.
However, these models have the drawback that they did not allow to determine the
isolated role of NHE3 in the small intestine or TAL. To get better insight, we generated
two novel mouse models to determine the contribution of NHE3 selectively in the
intestine as well as in the TAL: inducible intestinal epithelial cell specific (NHE3IEC-KO)
and inducible TAL-specific NHE3 knockout (NHE3TAL-KO) mice. The following 2
hypothesis have been tested:
Hypothesis I. NHE3 mediates the majority of neutral Na+ absorption in the
intestine, thereby determines systemic fluid and Na+ homeostasis, and also contributes
to acid-base balance, phosphate handling, intestinal structural integrity, and microbiota
homeostasis.
Hypothesis II. NHE3 in the TAL of the kidney contributes to renal Na+
reabsorption, acid-base regulation, urinary concentrating and acidification ability.
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CHAPTER TWO:
ROLE OF NHE3 IN THE INTESTINE

Introduction
Recessive missense, splicing and truncation mutations in NHE3 account for CSD
(Booth, Stange et al. 1985, Holmberg and Perheentupa 1985, Janecke, Heinz-Erian et
al. 2015), a potentially deadly condition due to massive fluid loss. Inhibition of intestinal
NHE3 by pro-inflammatory cytokines is a major contributor to diarrhea in patients with
inflammatory bowel disease (IBD) (Rocha, Musch et al. 2001, Barmeyer, Harren et al.
2004, Siddique, Hasan et al. 2009). In addition, intestinal NHE3 also plays an important
part in maintaining microbial homeostasis within the gut and contributes to dysbiosis in
IBD (Laubitz, Harrison et al. 2016). Whole body NHE3 knockout (NHE3-/-) mice exhibit
mild diarrhea, mild metabolic acidosis, dilation of the intestinal tract, hypotension
(Schultheis, Clarke et al. 1998) and are highly susceptible to experimental colitis (Kiela,
Laubitz et al. 2009, Larmonier, Laubitz et al. 2011), indicating that Na+ and H+ exchange
has broader implications for the body. Metabolic acidosis in NHE3-/- mice could result
from both the HCO3- reabsorption defect in the renal tubule and/or alkaline diarrhea
(Schultheis, Clarke et al. 1998, Wang, Yang et al. 1999). In contrast to the metabolic
acidosis observed in NHE3-/- mice, NHE3Pax8cre mice show no apparent abnormality in
acid-base homeostasis with the only finding being a higher urinary pH (Fenton, Poulsen
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et al. 2017). This possibly indicates a more prominent role of intestinal NHE3 for acidbase homeostasis. It was concluded that, as a consequence of defective intestinal and
renal absorption, NHE3-/- mice show hypovolemia and hyponatremia with resultant
hypotension (Schultheis, Clarke et al. 1998, Ledoussal, Lorenz et al. 2001, Li, Shull et
al. 2015). As a compensatory response to hypovolemia and hyponatremia, the renin
angiotensin aldosterone system (RAAS) is activated in NHE3-/- mice, indicated by
elevated plasma renin, angiotensin II and aldosterone levels (Schultheis, Clarke et al.
1998, Li, Shull et al. 2015). (Re)absorption defects in both the intestine and the kidneys
of NHE3-/- mice complicated the determination of the intestinal versus renal role of
NHE3. Based on the critical role of NHE3 for Na+ and fluid absorption, pharmacological
developments targeting NHE3 became an intriguing and potential treatment for
hypertension, chronic kidney disease (CKD) and constipation. Two small molecules,
orally nonabsorbable NHE3 inhibitors, SAR218034 and tenapanor have been
developed (Linz, Wirth et al. 2012, Spencer, Labonte et al. 2014). SAR218034
treatment significantly increased fecal Na+ and water excretion and decreased systolic
blood pressure in both lean and obese SHRs (Linz, Wirth et al. 2012). Furthermore,
coadministration of SAR218034 with ramipril (ACE inhibitor) resulted in an additive
effect on reduction of blood pressure compared to use of ramipril alone. These findings
show the therapeutic potential of specific intestinal NHE3 inhibition in the treatment of
hypertension. Tenapanor was just recently approved by the FDA for the treatment of
constipation-predominant irritable bowel syndrome (IBS-C) (Markham 2019). Inhibition
of NHE3 by tenapanor decreased intestinal Na+ and water absorption in healthy human
volunteers (Spencer, Labonte et al. 2014, Johansson, Rosenbaum et al. 2017, King,
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Siegel et al. 2018). Of note, in addition to suppressed Na+ uptake, tenapanor treatment
decreased intestinal inorganic phosphate (Pi) absorption accompanied by reduced Pi
excretion in the urine (Labonte, Carreras et al. 2015, King, Siegel et al. 2018), showing
positive effects on Pi management in a rat model of chronic kidney disease and
vascular calcification. Similarly, results from two recent randomized trials also reported
that tenapanor alone, or combined with Pi binder, showed remarkable serum Pilowering effect in patients on maintenance hemodialysis (Block, Rosenbaum et al. 2019,
Pergola, Rosenbaum et al. 2021). Experiments on human intestinal cell monolayers
have shown NHE3 inhibition by tenapanor increased transepithelial electrical resistance
(TEER), indicative of decreased paracellular permeability to Pi (King, Siegel et al.
2018). However, how intestinal inhibition of NHE3 has secondary consequences on
intestinal Pi transport is incompletely understood.
To date, no IEC specific NHE3 knockout mouse model has been generated.
NHE3-/- mice have a high mortality rate subsequent to weaning, with only ~30% of mice
surviving into adulthood (Bradford, Sartor et al. 2009). Due to absorption defects in both
the intestine and kidney, NHE3-/- mice do not tolerate a Na+-restricted diet, consequently
suffering from severe dehydration, weight loss, and death (Ledoussal, Lorenz et al.
2001). Also, a high NaCl diet (5% NaCl) does not rescue or compensate for Na+ and
water loss, instead results in NHE3-/- mice suffering from an even more severely swollen
small intestine and consequent death (Woo, Noonan et al. 2003). This was attributed to
the osmotic effect of high luminal NaCl. These results show the critical importance of
NHE3 in NaCl and water homeostasis. Our lab previously generated conditional
intestinal epithelial specific NHE3 knockout mice using a non-inducible VillinCre driver,
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which showed almost 100% postnatal mortality, with only one mouse surviving ~2
weeks (out of >50 offspring) (Dominguez Rieg, de la Mora Chavez et al. 2016).
Therefore, generation of NHE3IEC-KO mice should provide valuable novel insights for: (i)
determining intestinal pathologies caused by lack of NHE3, (ii) the link between NHE3
and phosphate transport, (iii) the role of intestinal NHE3 for blood pressure regulation,
(iv) determining if unspecific effects of non-absorbable NHE3 inhibitors exist and, (v)
determining the role of NHE3 on the microbiome.

Methods
Animals and experimental protocols. All animal experimentation was
approved by the local Institutional Animal Care and Use Committee at the University of
South Florida, and mice were housed in 12:12-h light/dark cycle with free access to
standard chow(TD.2018, Envigo, Madison, WI) and water and cared for in accordance
with the Guide for Care and Use of Laboratory Animals (National Institutes of Health,
Bethesda, MD) and. Villin-CreERT2 mice (Stock No: 020282) were purchased from
Jackson Laboratory (Bar Harbor, ME) and crossed with NHE3loxlox (Fenton, Poulsen et
al. 2015) to generate tamoxifen-inducible intestinal-specific NHE3 knockout mice. The
final breeder pairs are female NHE3loxlox mice crossed with male NHE3IEC-KO mice,
which generated experimental NHE3IEC-KO and control (NHE3loxlox) mice. Polymerase
chain reaction from genomic DNA isolated from ear punch tissue was used to genotype
mice. To induce knockout of NHE3, mice were treated with tamoxifen, initially dissolved
in 5% (v/v) of ethanol followed by adding 95% (v/v) of corn oil, via oral gavage (volume
1% of body weight), for 5 consecutive days.
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Physiological Analysis. Body weight, fluid and food intake were determined
daily from one week before induction up to 27 days after induction. Blood was collected
for analysis from the retro-orbital plexus after mice were briefly anesthetized by
isoflurane one week before induction, and at the end of the experimental period. Urine
samples were collected by reflex urination holding mice over a clean petri dish.
Urine and blood analysis. Blood chemistry was determined by an OPTI® CCATS2 blood gas analyzer using an E-Cl Type cassette (OPTIMedical, Roswell, GA).
Urine osmolality was measured by an Osmomat 3000 (Gonotec GmbH, Berlin,
Germany). Urinary pH was measured using a pH electrode (9810BN, Fisher Scientific,
Pittsburgh, PA). A solid phase enzyme-linked immunosorbent assay (IBL America,
Minneapolis, MN) was used to measure plasma aldosterone. Blood glucose was
measured by a glucose meter (Contour, Bayer, Parsippany, NJ) from blood collected via
tail snip.
Intestinal permeability and fecal water content. The intestinal permeability
was assessed in vivo by oral gavage mice with fluorescein isothiocyanate (FITC)
conjugated-dextran (FD-4, molecular weight 3-5 kDa, Sigma-Aldrich, 22 mg/ml, 1% of
body weight) 2 weeks after tamoxifen induction. At 1, 2 and 4 hours after gavage, blood
from a tail snip was collected in 10 µl minicaps® (Hirschmann Laborgeräte, Eberstadt,
Germany). Blood samples were briefly centrifuged and diluted 1:10 in 0.5 mol/L HEPES
(pH 7.4) and concentrations of FD-4 were measured by a fluorescent microplate reader
(Cytation 3, Biotek, Winooski, VT). Freshly defecated stool was weighted and then
placed at 80°C for 24 hours to evapovate water and measure dry weight when mass
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was stable. Fecal water content was calculated as the difference between fresh weight
and dry weight.
Isolation of Intestinal Epithelial Cells. Intestinal epithelial cells were isolated by
calcium (Ca2+) chelation (Fenton, Murali et al. 2019). Mice were anesthetized briefly
under isoflurane and then euthanized for small intestine collection. The small intestine
flushed from the proximal end with 10 ml phosphate buffered saline (PBS, pH 7.4). The
pH of flushing solution was determined. The flushed intestine was everted with ligation
at one end, and then filled with Ca2+-free PBS containing 5 mmol/L
ethylenediaminetetraacetic acid (EDTA), pH 7.4. After ligation of other end, the everted
pieces were placed in 50 ml tubes containing 40 ml Ca2+-free PBS+EDTA and
incubated in a water bath at 37°C for 20 minutes. The tubes were vigorously shaken
every 5 minutes to release the epithelial cells. After 20 minutes, the sacs were removed
and the solution containing epithelial cells was split in half. After centrifugation, one
pellet was prepared for mRNA analysis the other pellet for Western blotting.
Morphological Analysis of the Intestine. In another set of mice, the length of
small intestine and colon, as well as small intestinal weight were measured after
removing from each animal. Afterwards, both small intestine and colon were flushed
with ice-cold PBS and then tissue was fixed overnight in 4% paraformaldehyde, paraffin
embedded, and sectioned at 4-6 μm. Hematoxylin and eosin (H&E) staining was
performed for morphometry. In H&E-stained small intestinal sections, villus length and
crypt depth were measured in 12-15 well-oriented crypt-villus units in both proximal and
distal intestine under a 40x-1000x infinity research laboratory compound microscope
with built in camera display. Apoptosis in the intestine was examined via cleaved
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caspase-3 staining. Intestinal sections were pre-treated with 3% H2O2 for 10 minutes,
then incubated in Antigen Decloaker (Biocare Medical, Concord, CA, USA) in boiling
water for 45 minutes for antigen retrieval. After cooling down, the sections were blocked
with 20% normal goat serum (Vector Laboratories, Burlingame, CA, USA). Rabbit
polyclonal cleaved caspase-3 antibody (1:100; Cell Signaling Technology, Beverly, MA,
USA) was used for primary antibody with incubation for 1 hour at room temperature.
After washing, goat anti-rabbit biotinylated secondary antibody (1:200; Vector
Laboratories) was incubated for 30 min at room temperature. After staining with
Vectastain Elite ABC reagent (Vector Laboratories), sections were counterstained with
hematoxylin, dehydrated, and mounted with coverslips. Quantification of apoptosis was
conducted by counting the number of cleaved caspase-3-positive cells in 100 welloriented contiguous crypts and 50 well-oriented villi per animal.
Analysis of Inflammation. The inflammation was examined in the H&E-stained
small intestinal and colon sections by using 4-point grading system: 0 = normal; 1 = mild
mucosal inflammation; 2 = moderate inflammation; 3 = severe transmural inflammation.
The analysis was conducted by a pathologist (Maryam Tahmasbi) who was blinded to
sample identity.
Immunofluorescence for intestinal and kidney sections. Mice were
anesthetized with ketamine/xylazine (100 and 10 mg/kg, respectively, 2 μl/g bw). A cut
will be made from the lower abdomen to the upper thorax and the heart will be exposed.
A 21g needle connected to a pressure-controlled perfusion system was used to
puncture the left ventricle. Pressure was maintained during perfusion at 120 mmHg.
After perfusion with PBS followed by 4% PFA in PBS, small intestine, colon and kidneys
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were removed and fixed overnight. Fixed small intestine, colon and kidneys tissues
were processed and sectioned as previously described (Dominguez, Samocha et al.
2013, Poulsen, Kristensen et al. 2017). Fluorescent staining was performed by
incubating with polyclonal antibody against NHE3 (SPC-400, StressMarq Biosciences,
Cadboro Bay, Victoria, British Columbia, Canada) and goat anti-rabbit Texas red 595
conjugated secondary antibody (TI-1000, Vector Laboratories, Burlingame, CA) was
used for visualization of NHE3 labeling. Sections were mounted onto Superfrost slides
(Fisher Scientific 12-550-15) with hardset antifade mounting medium with DAPI (H1500, Vector Laboratories). The labelled sections were imaged by an Olympus (Center
Valley, PA) FV1000 MPE Multiphoton Laser Scanning Microscope with a 40x UPLFL
objective lens (numerical aperture: 0.75).
Reverse-Transcription Quantitative Polymerase Chain Reaction. Freshly
isolated IECs and whole kidney were homogenized using a Tissue Tearor (Bartlesville,
OK) and QIAshredder (Qiagen, Valencia, CA) according to the manufacturer’s
instructions. The total RNA was extracted and purified using RNeasy Plus Mini Kit
(Qiagen). Reverse transcription was performed using a QuantiTect reverse transcription
kit (Qiagen) according to the manufacturer’s instructions. cDNA was amplified with
primer pairs specific for NHE3 (Mm01352478_g1, efficiency 98%) with GAPDH
(Mm99999915_g1) as a reference gene by using TaqMan™ Universal PCR Master Mix
(Fisher Scientific) in a QuantStudio 3 (Applied Biosystems, Foster City, CA). Template
concentration was 12.5 ng cDNA/25-µl reaction (performed in triplicates). The ΔΔCt
method, i.e., cycle thresholds (Ct), was used to calculate relative NHE3 gene
expression normalized to GAPDH expression.
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Immunoblots. After isolation, the whole kidney tissue and intestinal epithelial
cells were immediately homogenized in buffer (250 mmol/L sucrose, 10 mmol/L
triethanolamine (Sigma-Aldrich, St. Louis, MO), pH 7.2, containing protease inhibitor
and phosphatase inhibitor (Fisher Scientific)). The homogenate was centrifuged at
1,000 g for 15 minutes at 4°C, and then the supernatant further centrifuged at 17,000 g
for 30 minutes at 4°C. Pellets were resuspended in homogenizing buffer and ready for
Western blotting. To enable equal lane loading (15 µg for kidney and 20 µg for
intestine), protein concentration was measured using a Bio-Rad DC Protein assay (BioRad Laboratories, Richmond, CA). Sample proteins were separated on 4-12% NuPAGE
gels in MOPS buffer (Fisher Scientific) and electroblotted to PVDF membranes (iBlot 2
transfer stacks, Invitrogen) which were blocked with Odyssey Blocking buffer (LI-COR
Bioscience, Lincoln, NE) and then incubated with primary antibodies overnight at 4°C,
followed by incubation with secondary antibodies for 1 hour at room temperature. We
used primary antibodies against NHE3 (dilution 1:500, rabbit, MilliporeSigma,
Burlington, MA), occludin (dilution 1:500, mouse, Invitrogen, Carlsbad, CA), ZO-1
(dilution 1:250, rabbit, Invitrogen) and -actin (dilution 1:30,000, mouse, Sigma-Aldrich;
dilution 1:5,000, rabbit, Proteintech, Rosemont, IL). Corresponding secondary
antibodies against rabbit or mouse were used and detected with an Odyssey® CLx (LICOR Biosciences). Signal quantification was performed by using Image Studio Lite (LICOR Biosciences).
Statistical analysis. Data are expressed as mean ± S.E.M. Statistical
differences between groups were analyzed by unpaired Student’s t test or MannWhitney U test. Differences between genotype and experimental conditions were
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analyzed by one-way analysis of variance (ANOVA) or 2-way mixed effects ANOVA
followed by two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli or
Tukey multiple comparison tests (all data analyzed via GraphPad Prism or SigmaPlot,
San Jose, CA, USA). Significance was considered at P < 0.05.

Results
Confirmation of NHE3 knockout in the intestine. Before tamoxifen
administration, NHE3lEC-KO mice were grossly indistinguishable from control mice and
born at expected Mendelian frequencies. However, starting 5 days after tamoxifen
administration the first mortality was observed in NHE3lEC-KO mice reaching ~25% after
3 weeks (Figure 5)

Figure 5. Mortality rate of NHE3lEC-KO mice.
NHE3lEC-KO mice had a mortality rate of ~25% 3 weeks after tamoxifen
administration
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In control mice, immunofluorescent labeling of NHE3 was found along the villi of
the small intestine (Figure 6A). In contrast, this labeling was completely absent in
NHE3lEC-KO mice after tamoxifen administration (Figure 6B). However, signal intensity
and localization of NHE3 labeling in the kidney was comparable between control and
NHE3lEC-KO mice (Figure 6C and D).
(A) Control

(B) NHE3IEC-KO

(C) Control

(D) NHE3IEC-KO

Figure 6. NHE3 label is absent in the intestine but not the kidney in tamoxifen
treated NHE3IEC-KO mice.
(A) NHE3 immunofluorescent labeling was found in the apical membrane of
enterocytes in control but not (B) NHE3IEC-KO mice. NHE3 label was not affected
in the kidney between (C) control and (D) NHE3IEC-KO mice.
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We further determined NHE3 mRNA and protein expression levels in the isolated
IECs and kidney tissue (Figure 7). After tamoxifen administration, NHE3 mRNA and
protein were undetected in IECs of NHE3IEC-KO mice (Figure 7A, B). However, renal
NHE3 protein expression was found to be 2-fold higher in NHE3IEC-KO compared to
control mice (Figure 7B), indicating a possible compensatory mechanism for loss of
NHE3 in the intestine. These data demonstrate the successful specific deletion of NHE3
in IECs.

(A)

(B)

Figure 7. NHE3 mRNA and protein expression are undetected in the epithelial cells of
tamoxifen treated NHE3IEC-KO mice.
No differences were found in renal NHE3 mRNA expression between NHE3IEC-KO and
control mice (A), while NHE3IEC-KO mice showed a 2-fold higher NHE3 protein
expression (B). Data are expressed as mean ± S.E.M. n = 4–6/genotype. *P < 0.05
versus control. Data were analyzed by unpaired Student’s t test.

Intestinal analysis of control and NHE3IEC-KO mice. Feces showed visible
signs of diarrhea in NHE3IEC-KO mice, which had ~1.45-fold higher fecal water content
compared to control mice (Figure 8). Consistent with global NHE3-/- mice, NHE3IEC-KO
mice also showed dilated intestines (Figure 9A), indicating increased intestinal content
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and defective absorption. Intestinal permeability analysis showed that NHE3IEC-KO mice
had ~1.9-fold higher FD-4 plasma concentrations 4 hours after administration compared
with control mice (Figure 9B). We further determined two major tight junction proteins
(occludin and zonula occludens 1, ZO-1) expressed in IECs and found that occludin
protein abundance was 28% lower in NHE3IEC-KO compared to control mice (Figure
10A). In contrast, no significant difference was found in ZO-1 abundance between two
groups (Figure 10B).

Control

NHE3IEC-KO

Figure 8. NHE3IEC-KO mice have diarrhea.
Fecal samples from NHE3IEC-KO mice showed visible signs of diarrhea and 1.45
fold higher water content compared with control mice. Data are expressed as
mean ± S.E.M. n = 7–8/genotype. *P < 0.05 versus control. Data were analyzed
by unpaired Student’s t test.
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NHE3IEC-KO

Control

Figure 9. NHE3IEC-KO mice have dilated intestine and higher intestinal permeability.
NHE3IEC-KO mice showed severe swelling of small intestine, cecum and colon, they
also had significantly increased intestinal permeability, ~1.9 fold higher FD-4
plasma concentrations 4h after administration compared to control mice. Data are
expressed as mean ± S.E.M. n = 9–12/genotype. *P < 0.05 versus control. Data
were analyzed by unpaired Student’s t test.
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(A)

(B)

Figure 10. Reduced occludin expression but unchanged ZO-1 in NHE3IEC-KO
mice.
NHE3IEC-KO mice showed 28% lower occludin protein abundance in the intestinal
epithelial cells (A) but comparable ZO-1 expression (B) compared to control
mice. Data are expressed as mean ± S.E.M. n = 5/genotype. *P < 0.05 versus
control. Data were analyzed by unpaired Student’s t test.

Histological examination showed that no inflammation was found in the small
intestine between genotypes. However, about 11% of NHE3IEC-KO mice had patchy
cryptitis with occasional crypt abscesses (Figure 11C, D) and 33% showed focal/patchy
mild cryptitis in the colon (Figure 11B, D). Of note, 56% of NHE3IEC-KO (Figure 11A, D)
and all control mice (Figure 11D) had no pathological findings. Results from cleaved
caspase-3 staining in intestinal sections showed that apoptosis in the crypts and tips of
villi in the small intestine in NHE3lEC-KO mice was ~2.4- and ~1.6-fold higher,
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respectively, compared to control mice (Figure 12). NHE3lEC-KO mice also showed ~1.9fold higher apoptosis in the colonic crypts compared to control mice (Figure 12).

(A) NHE3IEC-KO
Normal colon mucosa, colitis score 0

(B) NHE3IEC-KO
Abnormal colon mucosa, colitis score 1

(C) NHE3IEC-KO
Abnormal colon mucosa, colitis score 2

(D)

Figure 11. Histopathology of colon mucosa in NHE3IEC-KO mice.
(A) Normal colon mucosa of NHE3IEC-KO mice with colitis score 0. (B) Abnormal
colon mucosa in NHE3IEC-KO mice with colitis score 1, showing mild inflammation
and cryptitis. White errors indicate neutrophils between crypt epithelial cells. (C)
Abnormal colon mucosa in NHE3IEC-KO mice with colitis score 2, showing moderate
inflammation, cryptitis and crypt abscess. White errors indicate neutrophils, red
errors indicate crypt abscess.(D) Four out of nine NHE3IEC-KO mice show signs of
colitis.
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Figure 12. Quantification of cleaved caspase-3 positive cells shows increased
apoptosis in the intestine of NHE3IEC-KO mice. Data are expressed as mean ±
S.E.M. n = 4-6/genotype. *P < 0.05 versus control. Data were analyzed by
unpaired Student’s t test.
NHE3IEC-KO mice had more than 2-fold heavier non-flushed small intestines
compared to control mice (Figure 13A). Similarly, NHE3IEC-KO mice had ~2.5-fold higher
weight-to-length ratio of the small intestine (Figure 13B), which was not associated with
the overall small intestinal length (Figure 13C). However, colons from NHE3IEC-KO mice
were ~1.6 cm longer compared to control mice (Figure 13C). The total lengh of intestine
was not significantly different between NHE3IEC-KO and control mice (Figure 13C).
Analysis of villi length and crypt depth showed that villi in the proximal small intestine of
NHE3IEC-KO mice were ~100 µm longer compared to control mice, while villi length in the
distal small intestine and crypt depth in both the proximal and distal small intestine were
comparable between genotypes (Figure 13D). In control mice, the flush pH of the colon
was ~0.9 pH units lower compared to the small intestine (Figure 13E). However, no
significant difference between small intestinal and colonic flush pH were observed in
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NHE3IEC-KO mice (Figure 13E), and both small intestinal and colonic flush pH were
significant higher (~0.8 and ~1.6 pH units, respectively) than that of controls (Figure
13E).
(A)

(B)

(C)

(D)

(E)

Figure 13. NHE3IEC-KO mice have higher non-flushed intestinal weight and more alkaline
intestinal contents.
NHE3IEC-KO mice had (A) >2-fold heavier non-flushed small intestine and (B) 2.5-fold
higher weight-to-length ratio of the small intestine compared to control mice. NHE3IEC-KO
mice had (C) longer colon, but the length of small intestine was unchanged. (D) Longer
villi length was found in the proximal small intestine of NHE3IEC-KO mice, but no
differences were observed in villi length of distal small intestine or in crypt depth. (E)
NHE3IEC-KO mice had more alkaline small intestinal and colonic contents compared to
control mice. Data are expressed as mean ± S.E.M. n = 5/genotype. *P < 0.05 versus
control. Data were analyzed by unpaired Student’s t test.

31

Effect of tamoxifen administration on body weight, fluid and food intake in
control and NHE3IEC-KO mice .After tamoxifen (baseline) administration, no differences
were observed in body weight between NHE3IEC-KO and control mice (Figure 14A). Body
weight of control mice did not respond to tamoxifen, showing no change during or after
tamoxifen administration (Figure 14A). In contrast, during initial tamoxifen
administration, NHE3IEC-KO mice had a significant loss of body weight, followed by a
remarkable increase after tamoxifen administration (Figure 14A). The body weight gain
in the NHE3IEC-KO mice might be the consequence of fluid filled intestines (Figure 9).
The diarrhea was associated with a significantly increased fluid intake (see below).
Food intake in both NHE3IEC-KO and control mice showed similar responses to tamoxifen
administration, with a transient decrease during tamoxifen administration followed by a
return to baseline levels (Figure 14B). Of note, tamoxifen administration caused a
significantly greater decrease in food intake in NHE3IEC-KO mice (maximum -45%,
P<0.05 vs baseline) compared to control mice (maximum -25%, P<0.05 vs baseline).
Control mice had relative constant fluid intake during the whole experimental period
(Figure 14C). In contrast, NHE3IEC-KO mice had a fluid intake similar to control mice
during initial tamoxifen administration, but fluid intake was significantly increased three
days after tamoxifen administration compared to baseline and remained elevated for the
remainder of the experimental period (Figure 14C). Although NHE3IEC-KO mice had
increased fluid intake, they had ~2.8-fold higher blood urea nitrogen (BUN)
concentrations (76±16 vs 27±1, P<0.05) compared to control mice. When plotting
hemoglobin versus hematocrit all data points lie on the line of identity (Figure 14D);
however, the values of NHE3IEC-KO mice group significanlty higher compared to control
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mice consistent with a significantly higher hematocrit (50±2 vs 42±1%, P<0.05).
Together, the increased BUN concentration and hematocrit suggested dehydration and
volume depletion in NHE3IEC-KO mice.
Figure 14. NHE3IEC-KO mice have increased body weight and greater fluid intake.
(A)

(B)

(C)

(D)

(A) NHE3IEC-KO mice had a significant loss of body weight during initial tamoxifen
administration, followed by a remarkable increase (B) Tamoxifen administration caused
a transient decrease in both control and NHE3IEC-KO mice (C) NHE3IEC-KO mice showed
higher fluid intake after tamoxifen administration. (D) NHE3IEC-KO mice showed
significantly increased hematocrit associated with higher hemoglobin concentration.
Data are expressed as mean ± S.E.M. n = 15-19/genotype. *P < 0.05 versus control, #P
< 0.05 versus baseline control, §P < 0.05 versus baseline NHE3IEC-KO. Data were
analyzed by mixed effects ANOVA followed by two-stage linear step-up procedure of
Benjamini, Krieger and Yekutieli.
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Blood physiological analysis in control and NHE3IEC-KO mice. NHE3IEC-KO and
control mice had comparable baseline physiological parameters including blood pH,
HCO3-, base excess, plasma Na+, K+ and aldosterone as well as blood glucose (Figure
15A-G). After tamoxifen administration, at the end of the experimental period, control
mice showed no change in blood pH (Figure 16A), base excess (Figure 16C), and
plasma K+ (Figure 16E); however, had significantly increased blood HCO3- (Figure 15B)
and plasma Na+ (Figure 15D) as well as significantly decreased aldosterone (Figure
15F) and blood glucose (Figure 15G). After tamoxifen administration, NHE3lEC-KO mice
had significantly decreased blood pH (Δ -0.16±0.04 pH units; Figure 11A), HCO3- (Δ 4±1 mmol/L; Figure 16B) and base excess (Δ -7±2 mmol/L; Figure 16C). NHE3lEC-KO
mice also showed significantly decreased plasma Na+ (Δ -10±3 mmol/L; Figure 16D),
which is consistent with impaired water and Na+ handling. Plasma K+ was significantly
increased (Δ 1.9±0.5 mmol/L; Figure 16E) in NHE3lEC-KO mice, which might be attributed
to the body’s effort to defend against metabolic acidosis in combination with
hypovolemia. NHE3lEC-KO mice had significantly increased plasma aldosterone levels (Δ
3085±551 pg/mL; Figure 12F) possibly to compensate for hypovolemia and
hyponatremia. This elevated plasma aldosterone level is responsible for, at least in part,
a ~4.6-fold higher ratio of urinary K+/Na+ in NHE3lEC-KO compared to control mice (12±3
vs 3±1, P<0.05).
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(A)

(E)

(B)

(F)

(C)

(D)

(G)

Figure 15. Baseline blood analysis before tamoxifen administration.
Before tamoxifen administration, no significant differences were found between
control and NHE3IEC-KO mice in (A) blood pH, (B) blood HCO3−, (C) base excess,
(D) Na+, (E) K+, (F) aldosterone or (G) glucose. Data are expressed as mean ±
S.E.M. n = 8/genotype. Data were analyzed by unpaired Student’s t test.
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(B)

(C)

(E)

(F)

(G)

(D)

Figure 16. NHE3IEC-KO mice showed acid-base and electrolyte disturbance after
tamoxifen administration.
At the end of experimental period, NHE3IEC-KO mice developed (A) lower blood pH, (B)
lower blood HCO3−, (C)more negative base excess, (D) hyponatremia, (E)
hyperkalemia and (F) hyperaldosteronism. (G) No change was found in glucose
levels, which were not different between two genotypes. Data are expressed as mean
± S.E.M. n = 9-11/genotype. *P < 0.05 versus control. #P < 0.05 versus baseline for
the same genotype. Data were analyzed by mixed effects ANOVA followed by Tukey’s
multiple comparison test.
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Discussion
CSD, caused by NHE3 gene mutations, is associated with a high risk of mortality
which is attributed to defective Na+ and H+ handling. The precise role of intestinal NHE3
in CSD has not been clarified due to the lack of a suitable animal model. Global NHE3
knockout mice have a high mortality rate, with only ~30% mice surviving into adulthood
(Bradford, Sartor et al. 2009). Non-inducible intestinal epithelial cells specific NHE3
knockout mice showed almost 100% postnatal mortality (Dominguez Rieg, de la Mora
Chavez et al. 2016). To address this problem, we generated tamoxifen-inducible
NHE3IEC-KO. After tamoxifen administration, deletion of NHE3 in the intestine was
confirmed by the absence of NHE3 mRNA and protein, the latter determined by
Western blotting and immunofluorescent labeling. The VillinCreERT2 mouse model used
in our studies is, in addition to being expressed in the intestine, also expressed in the
renal brush border membrane, which could possibly result in renal deletion of NHE3.
However, NHE3IEC-KO mice had unchanged NHE3 mRNA expression in the kidneys
compared to control mice. In addition, renal NHE3 protein expression was ~2-fold
higher compared to control mice, suggesting a possible compensatory mechanism. This
is consistent with previous studies showing that metabolic acidosis elevates renal NHE3
protein abundance without having an effect on NHE3 mRNA expression (Ambuhl,
Amemiya et al. 1996, Wu, Biemesderfer et al. 1996). Consequently, deletion of NHE3
driven by VillinCreERT2 does not occur in the kidneys. The data are consistent with
results from a recent study that showed no “off-target” effect of VillinCreERT2 found
outside the intestine (Rutlin, Rastelli et al. 2020). When Villin-CreERT2 mice were
crossed with Rosa26-mTmG reporter mice, the reporter gene expression was primarily
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constricted within the small intestine and colon with no extraintestinal Cre activity
observed except scattered expression in the testis. The reason why VillinCreERT2 is not
expressed in the kidneys remains elusive but may result from positional effects at the
site of chromosomal integration. This could be affected by various trans- and cisregulatory elements in different tissues. NHE3IEC-KO mice have an advantage over other
mouse models in mortality rate. For example, only ~30% NHE3-/- mice survive into
adulthood (Bradford, Sartor et al. 2009). Of note, the situation is even worse in noninducible IEC specific NHE3 knockout mice, which have a 100 % mortality rate two
weeks after birth (Dominguez Rieg, de la Mora Chavez et al. 2016). It seems likely that
loss of NHE3 in the kidney, to some extent, compensates for fatal impairment of
development and growth caused by constitutive deletion of intestinal NHE3 alone. In
contrast, NHE3IEC-KO mice show no abnormality in development and growth and can
survive into adulthood before tamoxifen administration. However, they still have a
mortality of ~25% three weeks after tamoxifen administration, but undoubtably this has
advantages when studying intestinal NHE3 compared to other models.
At the end of experiment, control mice showed elevation of blood HCO3- and
plasma Na+ associated with decreased plasma aldosterone levels, which could be a
consequence of tamoxifen administration. Clinically, tamoxifen has be used for decades
for the treatment of estrogen receptor-positive breast cancer (Jordan 2003).
Additionally, tamoxifen was reported to have beneficial cardiovascular effects on the
basis of its lipid-lowering properties (Clarke, Schofield et al. 2001, Cushman, Costantino
et al. 2001). However, the effect of tamoxifen on fluid and Na+ homeostasis has not
been well described, with only one study showing that tamoxifen attenuates the
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elevation of urinary Na+ excretion induced by lithium (Tingskov, Kwon et al. 2018).
Noteworthy, in that study, tamoxifen administration resulted in an increase in plasma
Na+ in control rats, which is in accordance with our findings in control mice after
tamoxifen administration. By contrast, after tamoxifen administration, NHE3IEC-KO mice
suffer from alkaline diarrhea, hyponatremia and metabolic acidosis, alongside activation
of RAAS and volume contraction, these phenotypes align with most characteristics of
CSD patients harboring NHE3 mutations. Our data emphasize the critical role of NHE3
in Na+ and fluid absorption, as well as H+ excretion in the intestine. Defective Na+ and
fluid absorption leads to dilated and fluid-filled intestine in NHE3IEC-KO mice. This is also
observed in NHE3-/- mice, which is associated with more dilated apical junction complex
in the intestinal epithelium and high susceptibility to mucosal injury induced by dextran
sulfate sodium (Kiela, Laubitz et al. 2009). Disturbance of intestinal apical junction
complex in NHE3-/- mice can be attributed to, at least in part, the developmental effects
of NHE3 in maintenance of intestinal cell junctions and integrity. Consistently, in our
study, plasma levels of FD-4 are significantly increased 4 hours after administration in
adult NHE3IEC-KO mice, proving evidence for elevated intestinal permeability. Our data
point to a critical role of NHE3 in the maintenance of epithelial integrity and cell-cell
interactions. Occludin and ZO-1 are two major tight junction proteins involved in
intestinal epithelial integrity and barrier functions (Al-Sadi, Khatib et al. 2011, Guan,
Watson et al. 2011). Protein expression analysis suggests that reduced occludin
abundance but not ZO-1 in the IECs of NHE3IEC-KO mice might contribute to increased
intestinal permeability. Changes in intestinal luminal pH, as observed in NHE3IEC-KO
mice, is another factor influencing intestinal barrier function and tissue homeostasis
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(Lim, Vedula et al. 2008, de Valliere, Vidal et al. 2015). It remains to be determined if
changes in IEC volume is different between genotypes. In addition, it has been reported
that patients and experimental animals with NHE3 deficiency are vulnerable to microbial
dysbiosis and inflammatory bowel disease (IBD) (Engevik, Aihara et al. 2013,
Larmonier, Laubitz et al. 2013, Janecke, Heinz-Erian et al. 2016, Harrison, Laubitz et al.
2018), which is characterized by increased IEC apoptosis and impaired barrier function
(Gunther, Neumann et al. 2013, Blander 2018). In accordance with these previous
reports, NHE3IEC-KO mice show increased apoptosis in both, small intestine and colon.
Additionally, a subset of NHE3IEC-KO mice develops mild to moderate active colitis.
Tenapanor, an orally non-absorbable NHE3 inhibitor, was just recently approved by the
FDA for the treatment of constipation-predominant irritable bowel syndrome (IBS-C)
(Markham 2019). Of note, inhibition of NHE3 by tenapanor does not appear to affect
intestinal epithelial barrier function, with no effect on tight junction protein localization
and trafficking (King, Siegel et al. 2018). This indicates that impaired intestinal epithelial
barrier function in NHE3-/- and NHE3IEC-KO mice is merely because of defective Na+/H+
exchange, but more a direct role of NHE3 as a scaffolding protein, which is not a
surprise based on the fact that NHE3 contains multiple binding sites for adaptor and
scaffold proteins, enabling it to form multiprotein complexes with other transporters and
regulatory factors (Donowitz, Cha et al. 2005, Cha and Donowitz 2008).
In terms of intestinal architecture, NHE3IEC-KO mice showed unchanged small
intestine and increased colon length, the latter is likely a compensatory response to
chronic exposure of colon to greatly increased volume/electrolyte amounts resulting
from absorptive defects in the small intestine and proximal colon. Although increased
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apoptosis is found in IECs, NHE3IEC-KO mice develop longer villi in the proximal small
intestine, which is indicative of increased mucosal mass. This is evidenced in NHE3-/mice, which have a ~6-fold greater yield of intestinal epithelial cells per unit length of
intestinal segment compared to wild-type mice (Kiela, Laubitz et al. 2009). Similarly, a
mouse model of short bowel syndrome, which is generated by ileocecal resection, was
reported to have a more than 2-fold increase in villus length and crypt depth compared
to sham mice (Berlin, Reiner et al. 2019). Of note, longer villi could be considered
maladaptive, which are not associated with a better outcome after surgery. If the
increased villus length in NHE3IEC-KO mice could be a result of an elevated proliferation
rate of the epithelial cells, needs to be determined. For example, both proliferation and
apoptosis are increased in dextran sulfate sodium (DSS)-induced colitis in rats
(Vetuschi, Latella et al. 2002). However, one study reported that NHE3-/- mice showed
no significant changes in epithelial cell apoptosis or proliferation along the crypt-villus
axis (Kiela, Laubitz et al. 2009), which is consistent with comparable villus length and
crypt depth between NHE3-/- and WT mice.
NHE3-/- mice have shown clear metabolic acidosis, which can be ascribed to the
defective HCO3- reabsorption in the renal tubule and/or the alkaline diarrhea state
caused by disrupted Na+ and fluid uptake in the intestine (Schultheis, Clarke et al. 1998,
Wang, Yang et al. 1999). However, the former is not supported by findings in
NHE3Pax8cre (Fenton, Poulsen et al. 2017) or NHE3TAL-KO mice (discussed in the
following chapter), both showing no apparent abnormality in acid-base homeostasis.
This argues against Na+/H+ exchange in the kidneys being the primary determinant of
acid-base homeostasis. In contrast, NHE3IEC-KO mice show lower blood HCO3- and
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lower base excess, consistent with metabolic acidosis. Other systemic mechanisms for
acid-base regulation in the kidneys and lungs seem unable to compensate for the acidbase disturbance caused by loss of NHE3 in the intestine. Therefore, our data point to
the essential physiological role of intestinal NHE3 in the maintenance of acid-base
homeostasis, as evidenced in a previous study which showed that intestinal NHE3
activity, and abundance, were elevated in response to NH4Cl-induced metabolic
acidosis (Lucioni, Womack et al. 2002).
NHE3 accounts for the majority of transepithelial Na+ and fluid absorption in the
intestine. Supporting this role, NHE3IEC-KO mice show hyponatremic dehydration, which
is evidenced by significantly higher hematocrit and BUN levels, both indirect signs of
hypovolemia. Of note, the GFR in NHE3IEC-KO mice was not determined, therefore, we
cannot completely rule out the possibility that the increased BUN levels are due to a
reduction in GFR. To maintain fluid balance in the body, a hypovolemic state can trigger
arginine-vasopressin secretion and increased thirst sensation, the former promotes
water reabsorption in the renal collecting duct contributing to urinary concentration; the
latter enhances fluid intake, acting together to compensate for intestinal fluid loss.
Indeed, NHE3IEC-KO mice show significantly increased fluid intake. However, due to
intestinal absorptive defect, more fluid intake in NHE3IEC-KO mice contributes little to
attenuate hypovolemia but exacerbates diarrhea and intestinal dilation. In addition,
hypovolemia can also activate RAAS, which elevates Na+ reabsorption in the proximal
tubule but reduces distal Na+ delivery, resulting in Na+/K+ exchange in the distal
segments of the kidneys. This is partially responsible for the hyperkalemia in NHE3IEC-KO
mice, while the drastic metabolic acidosis is believed to be the primary contributing
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factor for hyperkalemia. Both, hyperkalemia and hyperaldosteronism are common
features of patients with CSD (Kidowaki, Funaki et al. 1993, Muller, Wijmenga et al.
2000, Janecke, Heinz-Erian et al. 2015).
In summary, we successfully generated an inducible IEC-specific NHE3 knockout
mouse model. NHE3IEC-KO mice show alkaline diarrhea, hyponatremic dehydration,
metabolic acidosis, moderate colitis and impaired intestinal integrity, providing several
lines of evidence that intestinal NHE3 plays critical roles in electrolyte and fluid balance,
acid-base regulation and intestinal tissue homeostasis. This novel mouse model
represents and explains the characteristics of CSD patients carrying mutations in
SLC9A3. The NHE3IEC-KO model is a translatable tool that will provide an understanding
of the mechanisms of action of novel intestinal-specific NHE3 inhibitors for the treatment
of IBS-C or hyperphosphatemia as well as potential side effects of these drugs.

43

CHAPTER THREE:
ROLE OF NHE3 IN THE THICK ASCENDING LIMB OF THE KIDNEY

Introduction
In the kidney, NHE3 is expressed in the proximal tubule (PT) and the thick
ascending limb (TAL). The contribution of NHE3 in the PT has been extensively studied;
however, studies looking at the role of NHE3 in the TAL are sparse.

Figure 17. Expression levels of NHE3 protein along nephron of rat (Limbutara,
Chou et al. 2020)
NHE3 protein is abundantly expressed in the S1 and S2 segments of the PT as
well as cortical and medullary TAL, with marginal expression found in thin
descending limb but not in the S3 segment of the PT. Color scheme showing
expression levels

Our own semiquantitative analysis identified that the signal intensity of NHE3 in
the TAL was stronger compared to the PT (Fenton, Poulsen et al. 2017). Transcriptional
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profiling shows that in the PT NHE3 has the highest expression in the S2 segment,
lower expression in the S1 segment and lack of expression in the S3 segment. In the
medullary TAL expression levels are comparable to the S2 segment; however, in the
cortical TAL, expression levels are ~3.4-fold higher compared to the S2 segment (Lee,
Chou et al. 2015). Similarly, translational profiling reveals that NHE3 protein is primarily
expressed in the S1 and S2 segments of the PT as well as cortical and medullary TAL,
with marginal expression found in thin descending limb and no expression in the S3
segment of the PT (Figure 17) (Limbutara, Chou et al. 2020).
Physiologically, it has been demonstrated that NHE3 activity in the TAL
responded to changes in peritubular fluid osmolality. Peritubular hyperosmolality inhibits
NHE3 activity and HCO3- reabsorption in the medullary TAL (Watts and Good 1994,
Good 1995). In contrast, hyposmolality stimulates NHE3 activity and HCO3reabsorption (Watts and Good 1999), which may contribute to urinary acidification by
diuretics, diuretic resistance and possibly contributes to renal Na+ retention in
edematous states. Furosemide, a diuretic acting on NKCC2 in the TAL, is used to test
for diverse renal disorders resulting in an inability to acidify the urine of humans. A
recent study in mice described that furosemide-induced urinary acidification and net
acid excretion were markedly reduced by NHE3 inhibition (de Bruijn, Larsen et al.
2015), which provides new insights into the contribution of NHE3 in the TAL for
furosemide-induced urinary acidification. When rats were exposed to chronic metabolic
acidosis, NHE3 protein abundance in the TAL was increased (Ambuhl, Amemiya et al.
1996, Kim, Ecelbarger et al. 1999). In contrast, metabolic alkalosis was not associated
with changes in NHE3 expression. Another study found that 72-hour water deprivation
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increased outer medullary NHE3 expression in young rats (Amlal and Wilke 2003). In
our previous study, 18-hour water deprivation (WD) on 0.8% NaCl diet showed that
NHE3Pax8Cre mice were unable to reach the same urine osmolality compared to control
mice. After 7 days of <0.01% dietary NaCl, NHE3Pax8Cre mice have impaired urinary
concentrating ability in response to 18-hour WD as evidenced by a lower urine
osmolality and greater increase in plasma osmolality compared with control mice. The
cortex cannot concentrate urine above isotonicity, which indicates that NHE3 in the
medullary TAL might be important for urinary concentrating ability (Fenton, Poulsen et
al. 2017). These studies provided evidence for involvement of NHE3 in the TAL in the
acid-base regulation of tubular fluid and urinary concentration. To date, no suitable
model was generated that allows for studying the physiological role of NHE3 in this
segment selectively. Therefore, we generated a novel TAL-specific NHE3 knockout
(NHE3TAL-KO) mouse model to study the isolated role of NHE3 in the TAL and to
investigate in vivo if NHE3 in the TAL is responsible for furosemide-induced urinary
acidification.

Methods
Animals and experimental protocols. All animal experimentation was approved
by the local Institutional Animal Care and Use Committee at the University of South
Florida, and mice were housed in 12:12-h light/dark cycle with free access to standard
chow (TD.2018, Envigo, Madison, WI) and water and cared for in accordance with the
Guide for Care and Use of Laboratory Animals (National Institutes of Health, Bethesda,
MD). UmodCreERT2 mice (Stock No.030601, The Jackson Laboratory, Bar Harbor, ME)
46

were purchased from Jackson Laboratory (Bar Harbor, ME) and crossed with NHE3loxlox
(Fenton, Poulsen et al. 2015) to generate tamoxifen-inducible TAL-specific NHE3
knockout (NHE3TAL-KO) mice. The final breeder pairs are female NHE3loxlox mice crossed
with male NHE3TAL-KO mice, which generate experimental NHE3TAL-KO and control
(NHE3loxlox) mice. Polymerase chain reaction from genomic DNA isolated from ear punch
tissue was used to genotype mice. To induce knockout of NHE3, mice were treated with
tamoxifen, initially dissolved in 5% (v/v) of ethanol followed by adding 95% (v/v) of corn
oil, via oral gavage (volume 1% of body weight) for 5 consecutive days.
Physiological Analysis. Body weight, fluid and food intake were determined daily
from one week before induction up to two weeks after induction. Blood was collected for
analysis from the retro-orbital plexus after mice were briefly anesthetized by isoflurane
one week before induction, plus at the end of the experimental period. Urine samples
were collected by reflex urination holding mice over a clean petri dish.
Urine and blood analysis. Blood chemistry was determined by an OPTI® CCATS2 blood gas analyzer using an E-Cl Type cassette (OPTIMedical, Roswell, GA). Urine
osmolality was measured by an Osmomat 3000 (Gonotec GmbH, Berlin, Germany), Na+
and K+ by flame photometry (BWB Technologies Ltd, Berkshire, UK), Cl- and creatinine
using commercial enzymatic assays (Thermo Fisher Scientific, Waltham, MA) and Pi and
Ca2+ by commercial photometrical assays (Pointe Scientific, Canton, MI). Urinary pH was
measured by a pH electrode (9810BN, Fisher Scientific, Pittsburgh, PA).
GFR measurement. GFR in conscious NHE3TAL-KO and control mice was
measured by plasma FITC-sinistrin (Fresenius-Kabi, Linz, Austria) clearance following a
single i.v. bolus injection (Rieg 2013). Mice were anesthetized briefly with isofluorane.
47

FITC-sinistrin (2% in isotonic saline solution, 2 μl/g BW) was injected into the retroorbital
plexus by using a G30½ needle. Blood was collected into 10 μl heparinized minicaps
(Hirschmann Laborgeräte, Eberstadt, Germany) at the following time points: 3, 5, 7, 10,
15, 35, 55, 75 minutes by the tail vein. After centrifugation, plasma was diluted 1:10 in 0.5
mol/L HEPES (pH 7.4) and the fluorescence of FITC-sinistrin was detected by a plate
reader (Cytation 3, Biotek, Winooski, VT) and GFR was calculated via a 2-phase
exponential decay model (GraphPad Prism, San Diego, CA).
Immunofluorescence for kidney section. Mice were anesthetized with
ketamine/xylazine (100 and 10 mg/kg, respectively, 2 μl/g bw). A cut will be made from
the lower abdomen to the upper thorax and the heart will be exposed. A 21g needle
connected to a pressure-controlled perfusion system was used to puncture the left
ventricle. Pressure was maintained during perfusion at 120 mm Hg. After perfusion with
PBS followed by 4% PFA in PBS, kidneys were removed and fixed overnight. Fixed
kidneys tissues were processed and sectioned as previously described (Dominguez,
Samocha et al. 2013, Poulsen, Kristensen et al. 2017). Triple fluorescent staining was
performed by incubating with polyclonal antibody against NHE3 (SPC-400, StressMarq),
monoclonal antibody against NKCC2 (SC-293222, Santa Cruz) and lotus tetragonolobus
lectin (LTL, Vector Laboratories, B-1325). Goat anti-rabbit Texas red 595 conjugated
secondary antibody (Vector Laboratories, TI-1000) was used for visualization of NHE3
labeling; Alexa Fluor donkey anti mouse 488 (Life Technologies, A-21202) was used for
NKCC2 visualization; DyLight 649 streptavidin (Vector Laboratories, SA-5649) was used
for LTL visualization in the PT. The labelled sections were imaged by an Olympus (Center
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Valley, PA) FV1000 MPE Multiphoton Laser Scanning Microscope with a 40x UPLFL
objective lens (numerical aperture: 0.75).
Reverse-Transcription Quantitative Polymerase Chain Reaction. Mice are
anesthetized briefly by isoflurane and then euthanized for tissue collection. The kidneys
were microdissected to collect inner medulla/inner stripe outer medulla (ISOM) and renal
cortex separately. Microdissected renal ISOM and cortex tissues were homogenized
using a Ultrasonic Homogenizer (Series 60 Sonic Dismembrator Model F60, Fisher
Scientific) and QIAshredder (Qiagen, Valencia, CA) according to the manufacturer’s
instructions. The total RNA was extracted and purified using RNeasy Plus Mini Kit
(Qiagen). Reverse transcription was performed using a QuantiTect reverse transcription
kit (Qiagen) according to the manufacturer’s instructions. cDNA was amplified with primer
pairs

specific

for

NHE3

(Mm01352478_g1,

efficiency

98%)

and

SGLT2

(Mm00453831_m1, efficiency 98%) with GAPDH (Mm99999915_g1) as a reference gene
by using TaqMan™ Universal PCR Master Mix (Fisher Scientific) in a QuantStudio 3
(Applied Biosystems, Foster City, CA). Template concentration was 12.5 ng cDNA/25-µl
reaction (performed in triplicates). The ΔΔCt method, i.e., cycle thresholds (Ct), was used
to calculate relative NHE3 and SGLT2 gene expression normalized to GAPDH expression.
Acute responses to furosemide. Acute responses to furosemide were assessed
in anesthetized mice as previously described (Eraly, Vallon et al. 2006, Vallon, Rieg et al.
2008). Mice were anesthetized with thiobutabarbital (100 mg/kg bw i.p., 2 μl/g body weight;
Sigma-Aldrich, St. Louis, MO) and ketamine (100 mg/kg body weight i.m., 2 μl/g body
weight) as previously described (Huang, Wulff et al. 2004, Vallon, Grahammer et al. 2005).
Mice were placed on an operating table with the body temperature maintained at 37.5°C
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by a servo-controlled heating plate (RT; Effenberger, Munich, Germany). The trachea
was cannulated and 100% oxygen blown toward the tracheal tube throughout the
experiment. The right jugular vein was cannulated for continuous maintenance infusion
of 2.25% bovine serum albumin in 0.85% NaCl at a rate of 500 µl/hour/30 g body weight.
A catheter was placed into the bladder and served for urine collection. The above
preparation took about 15 minutes and then mice were allowed another 45 minutes to
stabilize before the experiment was started. After 45 minutes, baseline urine collections,
via the bladder catheter, were performed for 3 consecutive 5-minute periods. Then a
dose-response curve for furosemide (0.1, 0.3, 1, 3, and 10 mg/kg) was generated via
bolus application of furosemide (15 µl/30 g body weight, infusion rate 25 µl/minute). After
each bolus, allowing 2 minutes for furosemide distribution, urine was collected for 2
consecutive 5-minute periods before the next bolus was applied. Urinary flow rate was
calculated after urine weight was determined gravimetrically. Urine was analyzed as
above.
Statistical analyses. Data are expressed as mean ± S.E.M. Statistical
differences between groups were analyzed by unpaired Student’s t test or MannWhitney U test. Differences between genotype and experimental conditions were
analyzed by one-way analysis of variance (ANOVA) or 2-way mixed effects ANOVA
followed by two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli or
Tukey multiple comparison tests (all data analyzed via GraphPad Prism or SigmaPlot,
San Jose, CA, USA). Significance was considered at P < 0.05.
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Results
Confirmation of NHE3 knockout in the TAL of the kidney. NHE3TAL-KO mice
were born at predicted Mendelian frequencies, appeared grossly indistinguishable from
control mice, and developed normally. After tamoxifen administration, NHE3 deletion in
the TAL was confirmed by RT-qPCR for NHE3 in the microdissected inner medulla/inner
stripe outer medulla (ISOM) and renal cortex tissue (Figure 18), and triple
immunofluorescent labeling of lotus tetragonolobus lectin (LTL, PT marker), NKCC2 (TAL
marker) and NHE3 in kidneys of control and NHE3TAL-KO mice (Figure 19).
qPCR results showed that NHE3 mRNA expression in NHE3TAL-KO mice was
reduced by ~30% in the renal cortex and by ~94% in the medulla compared to control
mice (Figure 18A). SGLT2 mRNA expression was comparable in the cortex between
control and NHE3TAL-KO mice but nearly undetectable in the medulla, which indicates
adequate microdissection of cortex and medulla (Figure 18B). Control mice showed
NHE3 labeling overlapping with LTL in the PT and NKCC2 signal in the TAL. In
contrast, no immunofluorescence was observed for NHE3 in the TAL of NHE3TAL-KO
mice (Figure 19). These results indicate that this model has specific knockout of NHE3
in the medullary and cortical TAL.
Physiological analysis in the control and NHE3TAL-KO mice. After tamoxifen
administration, no differences were found in fluid intake, plasma osmolality, food intake,
hematocrit, and GFR between control and NHE3TAL-KO mice (Figure 20A, C-F).
NHE3TAL-KO mice had significantly lower urine osmolality compared to control mice
(1826±93 versus 2224±90 mOsm/kg, P<0.05) (Figure 20B). Analysis of acid-base and
electrolyte handling showed that, except for a significantly increased urinary
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K+/creatinine ratio in NHE3TAL-KO mice (Figure 21F), control and NHE3TAL-KO mice had
no differences in plasma Na+ (Figure 21A), K+ (Figure 21B), Cl- (Figure 21C), blood pH
(Figure 21D), urinary Na+/creatinine (Figure 21E), Cl-/creatinine ratios (Figure 21G), and
urinary pH (Figure 21H). NHE3TAL-KO mice had a significant decrease in urinary
Ca2+/creatinine ratio compared to control mice (0.148±0.008 versus 0.182±0.010
mmol/mmol, P<0.05) (Figure 22D). No differences were observed in plasma Pi (Figure
22A), calcium (Figure 22B), and urinary Pi/creatinine (Figure 22C) between control and
NHE3TAL-KO mice.
(B)

(A)

Figure 18. NHE3 expression analysis in the cortex and medulla of control and
NHE3TAL-KO mice.
NHE3 mRNA expression in NHE3TAL-KO mice was reduced by ~30% in the renal
cortex and by ~94% in the medulla compared to control mice (A), SGLT2 mRNA
expression was comparable in the cortex but nearly undetected in the medulla
between control and NHE3TAL-KO mice (B). Data are expressed as mean ± S.E.M.
n = 8/genotype. *P < 0.05 versus control. Data were analyzed by unpaired
Student’s t test.
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Figure 19. Representative images of NHE3 localization in control and NHE3TAL-KO mice.
In control mice, NHE3 labeling (red) is overlapping with LTL labeling (blue) in the PT
and with NKCC2 (green) signal in the TAL. In contrast, Immunofluorescence for NHE3
is absent in the TAL in NHE3TAL-KO mice, indicating selective deletion in the TAL.
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Figure 20. Baseline physiological analysis in control and NHE3TAL-KO mice.
NHE3TAL-KO mice showed significantly lower urine osmolality compared to control mice
(B). No differences were found in fluid intake (A), plasma osmolality (C), food intake (D),
hematocrit (E), and GFR (F) between two genotypes. Data are expressed as mean ±
S.E.M. n = 8-20/genotype. *P < 0.05 versus control. Data were analyzed by unpaired
Student’s t test.
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Figure 21. Analysis of acid-base and electrolyte handling in control and NHE3TAL-KO
mice.
No differences were observed in plasma Na+ (A), K+ (B), Cl- (C), blood pH (D), urinary
Na+/creatinine (E), Cl-/creatinine ratios (G), and urinary pH (H) between control and
NHE3TAL-KO mice; however, NHE3TAL-KO mice had significantly higher urinary
K+/creatinine ratios compared to control mice (F). Data are expressed as mean ± S.E.M.
n = 20/genotype. *P < 0.05 versus control. Data were analyzed by unpaired Student’s t
test.
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(A)

(B)

(C)

(D)

Figure 22. Analysis of Pi and calcium handling in control and NHE3TAL-KO mice.
No differences were observed in plasma phosphate (A), calcium (B), and urinary
Pi/creatinine (C) between control and NHE3TAL-KO mice. NHE3TAL-KO mice showed a
significant decrease in urinary Ca2+/creatinine ratio compared to control mice (D). Data
are expressed as mean ± S.E.M. n = 18-20/genotype. *P < 0.05 versus control. Data
were analyzed by unpaired Student’s t test.
Acute response to furosemide in control, NHE3Pax8cre and NHE3TAL-KO mice.
Intravenous administration of furosemide resulted in comparable diuretic (ED50: 1.8±0.3
vs 1.2±0.2 mg/kg) (Figure 23A) and chloruretic (ED50: 1.6±0.3 vs 1.1±0.2 mg/kg) (Figure
23B) dose response curves between control and NHE3TAL-KO mice. The dose response
curve of urinary Cl-/creatinine ratio showed no differences between control and
NHE3TAL-KO mice (ED50: 1.1±0.2 vs 1.1±0.2 mg/kg) (Figure 24C).
To test the role of NHE3 in furosemide-induced urinary acidification, dose
response effects of urinary pH in response to furosemide were determined in control,
NHE3TAL-KO and NHE3Pax8cre mice. Urinary pH showed no response to furosemide up to
a dose of 0.1 mg/kg (Figure 24A, C) in control mice. At a dose of 0.3 mg/kg furosemide,
urinary pH significantly deceased (from 6.2±0.1 to 5.9±0.1, P<0.05), followed by a
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further decrease to 5.7±0.1 at a dose of 1 mg/kg furosemide. This level of acidification
was sustained throughout the application of 3 and 10 mg/kg (Figure 24A, B). In
NHE3TAL-KO mice, 0.1 and 0.3 mg/kg furosemide did not cause a significant urinary
acidification (Figure 24A). Application of 1 mg/kg furosemide resulted in a significant
decrease in urinary pH (from 6.0±0.1 to 5.7±0.1), that was followed by an immediate
increase (to 6.0±0.1). Urinary pH did not change with application of furosemide at doses
of 3 mg/kg and 10 mg/kg (Figure 24A, B). The urinary pH response to furosemide in
NHE3Pax8cre mice was similar to NHE3TAL-KO mice, except that application of 3 mg/kg
furosemide induced a second transient decrease in urinary pH (from 6.0±0.1 to 5.7±0.1)
(Figure 24C, D). However, no response of urinary pH was observed at a dose of 10
mg/kg furosemide (Figure 24C, D) in NHE3Pax8cre mice.
(A)

(B)

(C)

Figure 23. Acute diuretic and chloruretic response to furosemide in control, NHE3TAL-KO
and NHE3Pax8cre mice.
Diuretic (A), chloruretic (B) and urinary Cl-/creatinine ratio (C) dose response curves
showed no differences between genotypes. Data are expressed as mean ± S.E.M. n =
10-12/genotype.
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(A)

(C)

(B)

(D)

Figure 24. Acute response of urinary pH to furosemide in control, NHE3TAL-KO and
NHE3Pax8cre mice.
In control mice, furosemide at doses of 0.3 and 1 mg/kg resulted in a dose dependent
decrease in urinary pH, however, furosemide doses of 3 and 10 mg/kg did not further
acidify the urine (A, B). In NHE3TAL-KO mice, furosemide dose of 1 mg/kg caused a
transient drop in urinary pH, while it recovered and remained stable during the following
application of increased furosemide dose of 3 and 10 mg/kg (A, B). In NHE3Pax8cre mice,
furosemide induced two transient urinary acidifications at doses of 1 and 3 mg/kg
respectively (C, D). Data are expressed as mean ± S.E.M. n = 10-12/genotype. *P <
0.05 versus control. #P < 0.05 versus vehicle for control. §P < 0.05 versus previous
period NHE3Pax8cre. †P < 0.05 versus previous period NHE3TAL-KO. ‡P < 0.05 versus
previous period NHE3Pax8cre. Data were analyzed by mixed effects ANOVA followed by
two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli
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Discussion
In the kidney, NHE3 in the PT is the major transporter responsible for the
majority of Na+ and HCO3- reabsorption and therefore plays a critical role in extracellular
volume homeostasis, regulation of blood pressure and acid-base balance (Yip, Tse et
al. 1998, Girardi and Di Sole 2012, Fenton, Poulsen et al. 2017, Li, Soleimani et al.
2018, Li, Zhu et al. 2019). In contrast, the role of NHE3 in the TAL is less defined due to
a to a lack of a suitable animal model. To solve this problem, we developed a novel
tamoxifen-inducible NHE3TAL-KO mouse model. We used Umod-CreERT2 mice as the
driver, which was crossed with NHE3loxlox mice. Uromodulin is mainly expressed in the
TAL with very low expression in the early DCT and lack of expression in other nephron
segments (Tokonami, Takata et al. 2018). Regarding the latter, NHE3 is not expressed
in the DCT and therefore Umod-CreERT2 is the suitable driver for deleting NHE3 in the
TAL. With all employed methods (mRNA expression and immunofluorescent staining)
we were able to confirm deletion of NHE3 in response to tamoxifen in the TAL. A
remaining cortical NHE3 expression is consistent with the proximal tubules accounting
for the majority of structures located in the renal cortex. In contrast to our studies in
NHE3IEC-KO mice, we did not perform a paired analysis before and after tamoxifen
administration. During the time of breeding experimental mice, it became evident from
data supplied to the Jackson Laboratory by the donating investigator, that the Cre driver
in the TAL was “leaky”. Under normal conditions, Cre is not found in the nuclei and is
transitioned from the cytosol to the nuclei after tamoxifen administration. Being “leaky” is
evidence of Cre being found in nuclei without tamoxifen administration. We still
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administered tamoxifen in order to achieve complete deletion, but this Cre model should
rather be considered a “blend” of being conditional as well as inducible-conditional.
In contrast to the severe phenotype of NHE3-/- (Schultheis, Clarke et al. 1998,
Ledoussal, Lorenz et al. 2001) and NHE3IEC-KO (Xue, Thomas et al. 2020) mice, kidneyspecific (NHE3Pax8cre) (Fenton, Poulsen et al. 2015, Fenton, Poulsen et al. 2017) and
PT-specific NHE3 knockout (Li, Du et al. 2013, Li, Soleimani et al. 2018) mice show
“mild” phenotypes in terms of fluid and salt homeostasis, as well as acid-base balance.
Based on this, it was unreasonable to expect a severe phenotype in NHE3TAL-KO mice.
Indeed, baseline physiological analysis shows overall similar findings in terms of food
intake, hematocrit, plasma osmolality, plasma concentrations of Na+, K+ and Cl-, blood
pH, or urinary pH, Na+/creatinine and Cl-/creatinine ratios. In terms of fluid homeostasis,
NHE3TAL-KO mice have a slightly but significantly lower urine osmolality, which is
associated with a tendency for higher fluid intake. These results demonstrate that
NHE3TAL-KO mice are in fluid and salt balance. The lower urine osmolality indicates a
possible minor defect in urine concentrating ability in NHE3TAL-KO mice. A urine
osmolality above isotonicity can only be achieved by a functional renal medullary
interstitial osmotic gradient. Considering that NHE3TAL-KO mice still concentrate their
urine to ~1800 mmol/kg under baseline conditions, indicates that the contribution of
NHE3 in the TAL is minor. Consistent with this, NHE3Pax8cre mice show a defective
urinary concentrating ability which is inversely correlated with NaCl intake (Fenton,
Poulsen et al. 2017). Taken together, these data support a role of NHE3 in the
medullary TAL for urinary concentrating ability by contributing to establish the medullary
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interstitial osmotic gradient. If the contribution under conditions of water restriction
becomes more prominent, remains to be determined.
Approximately 25-30% of filtrated Na+ is reabsorbed within the TAL (Mount
2014). Na+ uptake mediated by NHE3 is responsible for as much as 10-20% of this
transcellular reabsorption and ~50% is attributed to NKCC2 (Molony, Reeves et al.
1989). It is assumed that the remaining transport is mediated by the paracellular
pathway, driven by the lumen-positive membrane potential (Caceres and Ortiz 2019,
Gonzalez-Vicente, Saez et al. 2019). Pharmacological inhibition of NKCC2 by
furosemide results in natriuresis and can lead to volume depletion and hypotension
(Simon, Karet et al. 1996, Russell 2000, Starremans, Kersten et al. 2003). In contrast to
the natriuresis observed in response to NKCC2 inhibition, NHE3TAL-KO mice show no salt
wasting phenotype, which raises the question what portion of Na+ reabsorption in the
TAL is mediated by NHE3, or in other words, why is the renal Na+ handling not affected
by deletion of NHE3 in the TAL? We postulate that, at least in part, two possible
compensatory mechanisms contribute to the maintenance of Na+ homeostasis in
NHE3TAL-KO mice. One possibility is that the local (NKCC2) and/or distal
transporters/channels (NCC and ENaC) are exposed to a greater distal fluid and
electrolyte load and therefore could be upregulated in a compensatory manner. For
example, in PT-NHE3-/- mice, the abundances of SGLT2 (expressed in the S1 and S2
segments of the PT) and ENaC were found to be significantly increased (Li, Soleimani
et al. 2018). Likewise, both NCC and ENaC show increased expression/activity in
NHE3Pax8cre mice (Fenton, Poulsen et al. 2017). Surprisingly, in NHE3-/- (Brooks,
Sorensen et al. 2001, Amlal, Ledoussal et al. 2003), PT-NHE3-/- (Li, Soleimani et al.
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2018) and NHE3Pax8cre mice (Fenton, Poulsen et al. 2017), NKCC2 abundance was
decreased, which could be considered an anti-homeostatic response. Also noteworthy,
results from experiments studying the acute responses to furosemide did not show any
differences between the diuretic and chloruretic dose response curves in NHE3TAL-KO,
NHE3Pax8cre and control mice (see Figure 23). Additionally, it has been known that
increased delivery of fluid and Na+ into the distal nephron provides the driving force for
increased urinary K+ secretion via renal outer medullary K+ and big conductance K+
channels (Rieg, Vallon et al. 2007, Fenton, Poulsen et al. 2017), which is consistent
with the higher K+/creatinine found in NHE3TAL-KO mice. Another possible compensatory
response could be a reduced GFR via activation of TGF, which has been observed in
NHE3-/- (Magyar, Zhang et al. 2000, Brooks, Sorensen et al. 2001, Ledoussal, Lorenz et
al. 2001), tgNHE3-/- (Woo, Noonan et al. 2003), PT-NHE3-/- (Li, Soleimani et al. 2018)
and NHE3Pax8cre mice (Fenton, Poulsen et al. 2017). The reduced GFR is possibly a
result of TGF activation as a response to increased Na+ and fluid delivery to the macula
densa due to reduced Na+ and fluid reabsorption resulting from absence of NHE3 in the
PT and/or TAL. How the decreased expression of NKCC2 (Brooks, Sorensen et al.
2001, Fenton, Poulsen et al. 2017, Li, Soleimani et al. 2018) interplays with the higher
fluid/Na+ load at the macula densa, remains to be established. NHE3TAL-KO mice show
GFR that was comparable to control mice, which indicates that the contribution of NHE3
to Na+ absorption in the TAL, and therefore activation of TGF, must be small or
indicates that TGF resetting occurred.
The TAL accounts for ~25% of Ca2+ reabsorption via the paracellular pathway,
which is dependent on Na+ transport (Bindels 1993, Friedman 1998). There are two
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determinants for Ca2+ reabsorption in the TAL, first, the lumen-positive voltage providing
the driving force (Moor and Bonny 2016); second, the paracellular permeability created
by tight junction proteins, like claudin 14, 16 and 19 (Konrad, Schaller et al. 2006, Hou,
Renigunta et al. 2009, Toka, Al-Romaih et al. 2012). Dysfunction of the TAL (e.g. in
Bartter syndrome) as well as inhibiting NKCC2 by furosemide results in hypercalciuria
(Zacchia, Capolongo et al. 2018, Downie and Alexander 2021). We hypothesized that
NHE3 deletion in the TAL may lead to impaired TAL function and therefore could cause
renal calcium loss. However, our data are inconsistent with this notion and more work is
needed to understand the slightly but significant decreased urinary Ca2+/creatinine
ratios in NHE3TAL-KO compared to control mice.
It has been demonstrated that NHE3 plays an essential role in the maintenance
of acid-base homeostasis by mediating HCO3- reabsorption in the PT (~80% of HCO3reabsorption occurs) (Boron 2006, Wagner, Devuyst et al. 2009) and TAL (~15% of
HCO3- reabsorption occurs) (Good, Knepper et al. 1984, Good 1985, Capasso, Unwin
et al. 1991). In NHE3-/- mice, in situ microperfusion of the PT demonstrated a marked
reduction in HCO3- reabsorption. Similarly, in vitro microperfusion of the isolated PT
from PT-NHE3-/- mice showed significantly decreased HCO3- reabsorption (Li, Du et al.
2013). However, this is inconsistent with in vivo studies, showing that plasma pH and
HCO3- concentrations were not changed in the of PT-NHE3-/- mice compared to WT
mice (Li, Soleimani et al. 2018). Our data also show no clear disturbance of acid-base
balance in the NHE3TAL-KO mice under baseline conditions, which is comparable to
NHE3Pax8cre mice (Fenton, Poulsen et al. 2017). By studying experimental metabolic
acidosis, induced by chronic acid loading, numerous studies have reported increased
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NHE3 activity and abundance in the PT and TAL (Akiba, Rocco et al. 1987, Preisig and
Alpern 1988, Soleimani, Bizal et al. 1992, Ambuhl, Amemiya et al. 1996, Wu,
Biemesderfer et al. 1996, Laghmani, Borensztein et al. 1997). In addition, one study
found that H+ secretion via NHE3 in the TAL contributes substantially to furosemideinduced urinary acidification (de Bruijn, Larsen et al. 2015), a test that is clinically used
to study urinary acidification capability in humans (Batlle 1986). This newly proposed
mechanism argues against the prevailing traditional explanation for furosemide-induced
urinary acidification: inhibition of Na+ reabsorption via furosemide in the TAL triggers
increased Na+ delivery to further distal nephron segments, where the functional coupling
between ENaC and H+-ATPase results in an increase in Na+ reabsorption along with H+
excretion (Arruda and Kurtzman 1980, Hropot, Fowler et al. 1985, Kovacikova, Winter et
al. 2006). In order to get unprecedented insight, we conducted acute furosemide
response experiments in Con, NHE3Pax8cre and NHE3TAL-KO mice. Our data from control
mice showed that application of 0.3 mg/kg furosemide induced a rapid urinary
acidification, which reached a maximum at a furosemide dose of 1 mg/kg. We
hypothesized that in NHE3TAL-KO and NHE3Pax8cre mice urinary acidification in response
to furosemide should be completely absent if this mechanism predominates. In contrast
to our hypothesis, we found that the acute acidification was preserved in NHE3TAL-KO
and NHE3Pax8cre mice; however, acidification could not be sustained as found in control
mice. This transient urinary acidification might be a consequence of a rapid adaptative
response of the distal tubule to increased Na+ delivery, which is consistent with the
concept of voltage-dependent H+ excretion, which indicates functional that coupling
between ENaC and H+-ATPase in the distal tubule is partially required for furosemide64

induced urinary acidification (de Bruijn, Larsen et al. 2015). Of note, lack of NHE3 in the
TAL diminished the ability to sustain the transient urinary acidification.
Taken together, we successfully generated an inducible TAL-specific NHE3
knockout mouse model. NHE3TAL-KO mice show lower urine osmolality with a tendency
for higher water intake, suggesting that NHE3 in the TAL contributes to urinary
concentrating ability. The present study indicates that NHE3 in the TAL is required for
sustained but not immediate urinary acidification induced by furosemide, whereas the
importance of NHE3 in the TAL for the maintenance of long-term acid-base
homeostasis needs to be reconsidered. Although NHE3TAL-KO mice show overall no
overt phenotype under baseline conditions, the model offers the opportunity to further
study the role of NHE3 in the TAL for acid-base homeostasis under pathophysiological
conditions.
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CHAPTER FOUR:
SUMMARY AND CONCLUSIONS
The experiments outlined in this thesis address knowledge gaps regarding the
relative physiological roles of NHE3 in the intestine and TAL of the kidney, respectively.
I employed two tamoxifen inducible Cre drivers (Villin-CreERT2 and Umod-CreERT2) to
successfully generate new genetically modified mouse models, namely NHE3IEC-KO and
NHE3TAL-KO mice. After tamoxifen administration, the specific deletion of NHE3 in IECs
of NHE3IEC-KO mice and in the TAL of NHE3TAL-KO mice was confirmed, and the
phenotype of these two mouse models was extensively characterized by a variety of
techniques ranging from molecular biology to physiology and pathology, including RTqPCR, Western blotting, immunofluorescent imaging, immunohistochemistry, clinical
chemistry of blood and urine, in vivo intestinal permeability measurements, GFR
measurement via FITC-Sinistrin as well as studying mice in metabolic cages or under
anesthesia. Summarizing the data from this thesis, the conclusions are as follows:
a) Intestinal NHE3 plays significant roles in Na+ and volume homeostasis as well
as acid-base homeostasis as evidenced by hyponatremia, hypovolemia and
metabolic acidosis associated with drastically elevated plasma aldosterone
levels in NHE3IEC-KO mice.
b) NHE3IEC-KO mice developed alkaline diarrhea in combination with a dilated
small intestine, cecum and colon, and lack of intestinal NHE3 had
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consequences on structural integrity of the small intestine and colon as well
as colonic inflammation.
c) NHE3IEC-KO mice represent and explain the phenotype of individuals with CSD
carrying SLC9A3 mutations (NHE3 gene).
d) Under basal condition, NHE3TAL-KO mice showed a ~25% lower urine
osmolality associated with ~20% higher water intake, indicating that NHE3 in
the TAL contributes to urinary concentrating ability.
e) Deletion of NHE3 in the TAL causes no obvious effects on electrolyte (Na+, K+
and Cl-) or mineral (Ca2+ and Pi) homeostasis as well as GFR. However, an
increase in urinary K+/creatinine ratio was observed.
f) No phenotype related to acid-base homeostasis was observed in NHE3TAL-KO
(as well as NHE3Pax8Cre) mice under baseline conditions, suggesting that the
role of renal NHE3 in the maintenance of long-term acid-base homeostasis
needs to be reconsidered.
g) NHE3 in the TAL is required for sustained but not immediate urinary
acidification induced by furosemide.
These results improve the understanding of how the body maintains appropriate
amounts of salt and water as well as acid-base homeostasis, which has broad
implications for cardiovascular disease, gastrointestinal disorders and kidney health.
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CHAPTER FIVE:
PERSPECTIVES
NHE3IEC-KO and NHE3TAL-KO mice are two useful translatable tools that will
provide a comprehensive understanding of the mechanisms of action of NHE3 in the
intestine and kidneys under various physiological and pathophysiological conditions.
Several new topics emerged in light of these discoveries presented here, a few of the
most prominent are listed here:

a) Pi handling and homeostasis in the NHE3IEC-KO mice
Pharmacological inhibition of NHE3 by tenapanor, an orally non-absorbable
NHE3 inhibitor, was described to decrease intestinal Pi absorption accompanied
by reduced Pi excretion in urine (Labonte, Carreras et al. 2015, King, Siegel et al.
2018). Currently tenapanor is undergoing FDA approval to treat
hyperphosphatemia in CKD. Surprisingly, how intestinal blockade of NHE3 has
secondary consequences on intestinal Pi transport is incompletely understood.
NHE3IEC-KO mice will provide us with valuable new insights into the mechanistic
interaction of intestinal NHE3 and transcellular and/or paracellular Pi transport.
b) Effect of changes in intestinal pH on microbiome
Intestinal NHE3 could play an instrumental role, possibly due to changes of the
pH in intestinal content, on the composition of the microbiome and NHE3
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inhibition could be a contributor to dysbiosis in inflammatory bowel disease (IBD)
(Laubitz, Harrison et al. 2016). A subset of NHE3IEC-KO mice developed mild to
moderate active colitis. It has been reported that patients and experimental
animals with NHE3 deficiency are vulnerable to microbial dysbiosis and IBD
(Engevik, Aihara et al. 2013, Larmonier, Laubitz et al. 2013, Janecke, HeinzErian et al. 2016, Harrison, Laubitz et al. 2018), which is characterized by
increased IEC apoptosis and impaired barrier functions (Gunther, Neumann et al.
2013, Blander 2018). Microbiome analysis in NHE3IEC-KO mice will determine the
effects of intestinal NHE3 on gut microbiota composition and possible
consequences of dysbiosis on IBD.
c) Blood pressure analysis in both NHE3IEC-KO and NHE3TAL-KO mice under baseline
conditions and when challenged by dietary NaCl.
The importance of NHE3 in blood pressure regulation has been demonstrated in
various NHE3 transgenic mouse models, including NHE3-/- (Schultheis, Clarke et
al. 1998), tgNHE3-/- (Noonan, Woo et al. 2005, Li, Shull et al. 2015), NHE3Pax8cre
(Fenton, Poulsen et al. 2017) and PT-NHE3-/- mice (Li, Soleimani et al. 2018, Li,
Zhu et al. 2019). The blood pressure analysis in NHE3IEC-KO and NHE3TAL-KO
mice will improve the understanding of the contribution of intestinal NHE3 and
NHE3 in the TAL for blood pressure regulation.
d) Dietary acid-base challenges in NHE3TAL-KO mice
Under basal conditions, NHE3TAL-KO mice show no obvious phenotype regarding
acid-base homeostasis. This could mean that (i) there is no role of NHE3 in the
TAL for acid-base homeostasis and/or (ii) that further distal mechanisms are
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compensating. Performing dietary acid-base challenge in NHE3TAL-KO mice will
enable us to uncover a role of NHE3 in the TAL for acid-base homeostasis.
e) Chronic response to furosemide in NHE3TAL-KO mice
The results from acute response to furosemide experiment revealed the
contribution of NHE3 in the TAL for urinary acidification in response to
furosemide. It will be interesting to investigate the response of NHE3TAL-KO mice
to chronic furosemide treatment, which should also uncover other compensating
mechanisms in further distal nephron segments, which could be quite different
from control mice.
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APPENDIX I:
LIST OF ABBREVIATIONS

ANG II ········ angiotensin II
CD ············ collecting duct
CHP ·········· calcineurin homologous protein
CKD ·········· chronic kidney disease
CNT ·········· connecting duct
CSD ·········· congenital sodium diarrhea
DCT ·········· distal convoluted tubule
DPP-IV ······· dipeptidyl peptidase IV
DRA ·········· downregulated in adenoma
EDTA ········· ethylenediaminetetraacetic acid
ENaC ········· epithelial sodium channel
FDA ··········· food and drug administration
GFR ·········· glomerular filtration rate
GTB ·········· glomerulotubular balance
IBD ············ inflammatory bowel disease
IMCD ········· inner medullary collecting duct
NBCe1 ······· Na+/HCO3- cotransporter e1
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NCC ·········· Na+/Cl- cotransporter
NHERFs ····· sodium hydrogen exchanger regulatory family
NHEs ········· sodium hydrogen exchangers
NKCC2 ······ Na+/K+/2Cl- cotransporter
Npt2 ·········· type II Na+-dependent phosphate cotransporter
OMCD ······· outer medullary collecting duct
PAT1 ········· putative anion transporter 1
PBS ··········· phosphate buffered saline
PKA ··········· protein kinase A
Pi ·············· phosphate
PT ············· proximal tubule
PTH ··········· parathyroid hormone
RAAS ········ renin angiotensin aldosterone system
ROMK ········ renal outer medullar K+ channel
SGK1 ········· serum- and glucocorticoid-inducible kinase 1
SGLT ········· sodium-glucose cotransporter
SHR ·········· spontaneously hypertensive rats
TAL ··········· thick ascending limb
TEER ········· transepithelial electrical resistance
TGF ··········· tubuloglomerular feedback
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